


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:52:51Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405812" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405812</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="dar70011" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Rev</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Rev</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">DAR</journal-id><journal-title-group><journal-title>Drug and Alcohol Review</journal-title></journal-title-group><issn pub-type="ppub">0959-5236</issn><issn pub-type="epub">1465-3362</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405812</article-id><article-id pub-id-type="pmcid-ver">PMC12405812.1</article-id><article-id pub-id-type="pmcaid">12405812</article-id><article-id pub-id-type="pmcaiid">12405812</article-id><article-id pub-id-type="pmid">40755442</article-id><article-id pub-id-type="doi">10.1111/dar.70011</article-id><article-id pub-id-type="publisher-id">DAR70011</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Paper</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Relationship Between Patient&#8208;Reported Experiences and Treatment Satisfaction Among Men and Women in Residential Substance Use Treatment</article-title></title-group><contrib-group><contrib id="dar70011-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Haynes</surname><given-names initials="CJ">Chloe J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2779-5950</contrib-id><xref rid="dar70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>cjh893@uowmail.edu.au</email></address></contrib><contrib id="dar70011-cr-0002" contrib-type="author"><name name-style="western"><surname>Beck</surname><given-names initials="AK">Alison K.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9031-2117</contrib-id><xref rid="dar70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="dar70011-cr-0003" contrib-type="author"><name name-style="western"><surname>Kelly</surname><given-names initials="PJ">Peter J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0500-1865</contrib-id><xref rid="dar70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="dar70011-cr-0004" contrib-type="author"><name name-style="western"><surname>Kaip</surname><given-names initials="D">Dennis</given-names></name><xref rid="dar70011-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="dar70011-cr-0005" contrib-type="author"><name name-style="western"><surname>Wells</surname><given-names initials="M">Megan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6925-3677</contrib-id><xref rid="dar70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="dar70011-cr-0006" contrib-type="author"><name name-style="western"><surname>Issa</surname><given-names initials="J">Jaymee</given-names></name><xref rid="dar70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="dar70011-cr-0007" contrib-type="author"><name name-style="western"><surname>Kelly</surname><given-names initials="D">David</given-names></name><xref rid="dar70011-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="dar70011-cr-0008" contrib-type="author"><name name-style="western"><surname>Hides</surname><given-names initials="L">Leanne</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4550-8460</contrib-id><xref rid="dar70011-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="dar70011-cr-0009" contrib-type="author"><name name-style="western"><surname>Larance</surname><given-names initials="B">Briony</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3800-7673</contrib-id><xref rid="dar70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="dar70011-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">School of Psychology</named-content>
<institution>University of Wollongong</institution>
<city>Wollongong</city>
<country country="AU">Australia</country>
</aff><aff id="dar70011-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Odyssey House New South Wales</institution>
<city>Sydney</city>
<country country="AU">Australia</country>
</aff><aff id="dar70011-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>University of Queensland</institution>
<city>Brisbane</city>
<country country="AU">Australia</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold><break/>
Chloe J. Haynes (<email>cjh893@uowmail.edu.au</email>)<break/></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>44</volume><issue seq="80">6</issue><issue-id pub-id-type="pmc-issue-id">496084</issue-id><issue-id pub-id-type="doi">10.1111/dar.v44.6</issue-id><fpage>1691</fpage><lpage>1703</lpage><history><date date-type="rev-recd"><day>20</day><month>7</month><year>2025</year></date><date date-type="received"><day>01</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Drug and Alcohol Review</italic> published by John Wiley &amp; Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="DAR-44-1691.pdf"/><self-uri content-type="pdf" xlink:href="file:DAR-44-1691.pdf"/><abstract><title>ABSTRACT</title><sec id="dar70011-sec-0001"><title>Introduction</title><p>Understanding the experiences of women participating in residential alcohol and other drug (<styled-content style="fixed-case" toggle="no">AOD</styled-content>) treatment is important in ensuring treatment effectively meets women's needs. Patient&#8208;reported experience measures aid in assessing women's experiences of treatment but are often used to quantify women's treatment satisfaction without additional context regarding specific treatment experiences. This study examined the relationship between the domains of the <italic toggle="no">Patient Reported Experience Measure for Addiction Treatment (<styled-content style="fixed-case" toggle="no">PREMAT</styled-content>)</italic> and overall treatment satisfaction, including whether relationships differed by gender.</p></sec><sec id="dar70011-sec-0002"><title>Methods</title><p>
<italic toggle="no">N</italic>&#8201;=&#8201;138 participants (30.9% women) from a not&#8208;for&#8208;profit residential <styled-content style="fixed-case" toggle="no">AOD</styled-content> treatment service completed a survey regarding their experiences of and satisfaction with treatment, including the <styled-content style="fixed-case" toggle="no">PREMAT</styled-content>. Descriptives, chi&#8208;square and Mann&#8211;Whitney <italic toggle="no">U</italic> statistics examined gender differences in demographics. A generalised linear model assessed the relationship between <styled-content style="fixed-case" toggle="no">PREMAT</styled-content> domain scores and overall treatment satisfaction (Client Satisfaction Questionnaire), controlling for age and weeks in treatment, including whether relationships differed by gender. Relative weight statistics examined the relative statistical importance of each <styled-content style="fixed-case" toggle="no">PREMAT</styled-content> domain to overall satisfaction.</p></sec><sec id="dar70011-sec-0003"><title>Results</title><p>There were no gender differences on <styled-content style="fixed-case" toggle="no">PREMAT</styled-content> item, domain or total scores. Controlling for age and weeks in treatment, significant predictors of overall treatment satisfaction were the <styled-content style="fixed-case" toggle="no">PREMAT</styled-content> &#8216;self&#8208;determination and empowerment&#8217; and &#8216;personal responsibility&#8217; domains. The impact of &#8216;personal responsibility&#8217; on overall satisfaction was weaker for women compared to men.</p></sec><sec id="dar70011-sec-0004"><title>Discussion and Conclusions</title><p>Fostering individualised care and support, self&#8208;determination, empowerment and personal responsibility for care, are important aspects of residential treatment for both men and women. Further development of women&#8208;specific <styled-content style="fixed-case" toggle="no">PREMs</styled-content> that address gendered experiences of treatment is warranted.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="dar70011-kwd-0001">gender</kwd><kwd id="dar70011-kwd-0002">patient&#8208;reported experience measures</kwd><kwd id="dar70011-kwd-0003">person&#8208;centred care</kwd><kwd id="dar70011-kwd-0004">residential treatment</kwd><kwd id="dar70011-kwd-0005">treatment satisfaction</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Australian Government Research Training Program</institution></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="6"/><page-count count="13"/><word-count count="8700"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:03.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="dar70011-cit-1001"><string-name name-style="western"><given-names>C. J.</given-names><surname>Haynes</surname></string-name>, <string-name name-style="western"><given-names>A. K.</given-names><surname>Beck</surname></string-name>, <string-name name-style="western"><given-names>P. J.</given-names><surname>Kelly</surname></string-name>, et al., &#8220;<article-title>Relationship Between Patient&#8208;Reported Experiences and Treatment Satisfaction Among Men and Women in Residential Substance Use Treatment</article-title>,&#8221; <source>Drug and Alcohol Review</source><volume>44</volume>, no. <issue>6</issue> (<year>2025</year>): <fpage>1691</fpage>&#8211;<lpage>1703</lpage>, <pub-id pub-id-type="doi">10.1111/dar.70011</pub-id>.<pub-id pub-id-type="pmcid">PMC12405812</pub-id><pub-id pub-id-type="pmid">40755442</pub-id></mixed-citation>
</p><fn-group id="dar70011-ntgp-0001"><fn fn-type="funding" id="dar70011-note-0001"><p>
<bold>Funding:</bold> Chloe J. Haynes was supported by an Australian Government Research Training Program scholarship while conducting the research.</p></fn><fn fn-type="generalState" id="dar70011-note-0002"><p>Each author certifies that their contribution to this work meets the standards of the International Committee of Medical Journal Editors.</p></fn></fn-group></notes></front><body id="dar70011-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="dar70011-blkfxd-0001" orientation="portrait"><caption><title>Summary</title></caption><p>
<list list-type="bullet" id="dar70011-list-0001"><list-item id="dar70011-li-0001"><p>Patient&#8208;reported experience measures are under&#8208;utilised in substance use research.</p></list-item><list-item id="dar70011-li-0002"><p>Need to examine overall treatment satisfaction and gendered experiences that impact this satisfaction.</p></list-item><list-item id="dar70011-li-0003"><p>Self&#8208;determination and empowerment are essential for men and women's treatment satisfaction.</p></list-item><list-item id="dar70011-li-0004"><p>Personal responsibility is less important to women's treatment satisfaction than men's.</p></list-item><list-item id="dar70011-li-0005"><p>Further work is needed to develop patient&#8208;reported experience measures that capture women's specific and unique experiences.</p></list-item></list>
</p></boxed-text>
</p><sec id="dar70011-sec-0008"><label>1</label><title>Introduction</title><p>Substance use disorders (SUD) are a leading cause of death and disability [<xref rid="dar70011-bib-0001" ref-type="bibr">1</xref>, <xref rid="dar70011-bib-0002" ref-type="bibr">2</xref>], with an estimated 39.5 million people meeting SUD criteria worldwide [<xref rid="dar70011-bib-0003" ref-type="bibr">3</xref>]. Residential alcohol and other drug (AOD) treatment services provide structured care and support for people with SUDs who would benefit from 24/7 support in a more controlled environment due to complex social, physical and emotional factors [<xref rid="dar70011-bib-0004" ref-type="bibr">4</xref>, <xref rid="dar70011-bib-0005" ref-type="bibr">5</xref>, <xref rid="dar70011-bib-0006" ref-type="bibr">6</xref>]. Residential programs generally include withdrawal support, individual and group psychological support, mutual self&#8208;help and supported reintegration into the community [<xref rid="dar70011-bib-0005" ref-type="bibr">5</xref>, <xref rid="dar70011-bib-0006" ref-type="bibr">6</xref>]. Research has demonstrated the effectiveness of residential treatment in improving outcomes across a range of substance use and functioning domains [<xref rid="dar70011-bib-0005" ref-type="bibr">5</xref>, <xref rid="dar70011-bib-0006" ref-type="bibr">6</xref>, <xref rid="dar70011-bib-0007" ref-type="bibr">7</xref>]. While indicators of &#8216;success&#8217; (e.g., abstinence, symptom improvement and treatment retention) are important in evaluating residential services, health care's shift towards person&#8208;centred care has also led to a greater appreciation of client needs, preferences, values and experiences.</p><p>Person&#8208;centred care has been defined as &#8216;care that is respectful of, and responsive to, the preferences, needs and values of patients and consumers&#8217; [<xref rid="dar70011-bib-0008" ref-type="bibr">8</xref>, p. 1] or &#8216;treating patients as individuals and as equal partners in the business of healing&#8217; [<xref rid="dar70011-bib-0009" ref-type="bibr">9</xref>,&#160;p.&#160;114]. Person&#8208;centred care is particularly important among vulnerable populations, including people with SUDs, with people participating in AOD treatment consistently expressing their appreciation for having &#8216;a voice&#8217; in their care [<xref rid="dar70011-bib-0010" ref-type="bibr">10</xref>, <xref rid="dar70011-bib-0011" ref-type="bibr">11</xref>]. There has also been an increased understanding of the impact of gender on experiences of substance use and treatment, with it now generally recognised that the social construction of gender, and the specific and complex experiences of women, cannot be ignored [<xref rid="dar70011-bib-0012" ref-type="bibr">12</xref>, <xref rid="dar70011-bib-0013" ref-type="bibr">13</xref>, <xref rid="dar70011-bib-0014" ref-type="bibr">14</xref>]. For example, women who use substances often experience collective alienation regarding their role in society [<xref rid="dar70011-bib-0015" ref-type="bibr">15</xref>], as well as significant societal expectations [<xref rid="dar70011-bib-0016" ref-type="bibr">16</xref>], stigma [<xref rid="dar70011-bib-0017" ref-type="bibr">17</xref>, <xref rid="dar70011-bib-0018" ref-type="bibr">18</xref>], guilt and fear [<xref rid="dar70011-bib-0019" ref-type="bibr">19</xref>, <xref rid="dar70011-bib-0020" ref-type="bibr">20</xref>], and blame [<xref rid="dar70011-bib-0020" ref-type="bibr">20</xref>]. Coupled with the historically patriarchal nature of AOD research and treatment, this highlights the importance of understanding women's unique experiences of AOD treatment, particularly in order to advance person&#8208;centred care and ensure current treatment models are effectively meeting the needs of women.</p><p>Measures which significantly aid in a comprehensive person&#8208;centred care assessment include patient&#8208;reported experience measures (PREM; [<xref rid="dar70011-bib-0021" ref-type="bibr">21</xref>]), which gather important information on the client's experience of receiving treatment [<xref rid="dar70011-bib-0022" ref-type="bibr">22</xref>]. PREMs can include questions regarding client experience (i.e., factual responses about what did or did not occur during treatment) and client satisfaction (i.e., subjective responses about the quality of care) [<xref rid="dar70011-bib-0023" ref-type="bibr">23</xref>, <xref rid="dar70011-bib-0024" ref-type="bibr">24</xref>]. However, research has highlighted a general under&#8208;utilisation of PREMs in AOD research and treatment, particularly among women [<xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. Additionally, the reporting of PREM results often only includes an overall &#8216;satisfaction&#8217; score, without additional information regarding client experiences. For women, it has been noted that these results and conclusions often do not align with women's experiences where qualitative or mixed methods are used [<xref rid="dar70011-bib-0024" ref-type="bibr">24</xref>, <xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. Measures and methods which prioritise overall satisfaction scores are useful in making broad conclusions regarding the ability of treatment services to adequately cater to women. However, PREMs which focus more explicitly on women's unique experiences of treatment, rather than a reduction of women's experiences to a single numerical score, can more meaningfully inform clinical practice and service provision. As such, it has been suggested that the use of PREMs should include analysis of overall treatment satisfaction as well as examination of women's experiences with, or perceptions of, specific aspects of treatment which may impact this overall satisfaction [<xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>].</p><p>PREMs have been developed and used across many health care settings. However, Kingsley and Patel [<xref rid="dar70011-bib-0022" ref-type="bibr">22</xref>] note that choosing the correct PREM tool for the specific population and the data to be collected is crucial in obtaining relevant and meaningful experience data. In AOD research, the generally limited use of PREMs as well as the absence of AOD&#8208;specific PREMs have been identified as significant issues [<xref rid="dar70011-bib-0026" ref-type="bibr">26</xref>]. Hinsley et&#160;al. [<xref rid="dar70011-bib-0027" ref-type="bibr">27</xref>] helped to address these issues by developing a PREM specifically for residential AOD treatment services&#8212;the <italic toggle="yes">Patient Reported Experience Measure for Addiction Treatment</italic> (PREMAT). The PREMAT was developed through extensive consultation with people engaged in residential AOD treatment services using a process guided by recognised principles of person&#8208;centred care [<xref rid="dar70011-bib-0027" ref-type="bibr">27</xref>]. The resulting measure assesses client's experiences and satisfaction across specific aspects of person&#8208;centred care; for example, fast access to reliable health care, involvement in decisions and respect for preferences, attention to physical and environmental needs (see [<xref rid="dar70011-bib-0028" ref-type="bibr">28</xref>]). Kelly et&#160;al. [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>] conducted a preliminary psychometric evaluation and validation of the PREMAT among 178 participants (40.4% women) across six Australian residential treatment services and found that the PREMAT is a valid measure of experience, with &#8216;excellent&#8217; internal consistency and &#8216;strong&#8217; test&#8211;retest reliability. Principal component analysis identified six underlying domains: individualised support; self&#8208;determination and empowerment; program structure; treatment environment; coordination of care; and personal responsibility [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>]. There was also a strong correlation between the PREMAT and other measures of client satisfaction [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>].</p><p>The structure of the PREMAT provides a useful opportunity to examine client's experiences with specific aspects of residential treatment across a range of domains. In addition, little research exists that determines the relative importance or impact of different aspects of treatment on overall client satisfaction, including whether these impacts are gender specific. As such, the aim of the current study is to examine the relationship between each domain of the PREMAT and overall treatment satisfaction, including whether these relationships differ by gender. This study will provide valuable insights regarding the different experiences of residential treatment for men and women and inform service provision and potential adaptations to ensure men and women are satisfied with their care. This study will also contribute to improving the evidence base for the PREMAT as a measure of client experiences in residential AOD treatment, particularly for women.</p></sec><sec sec-type="methods" id="dar70011-sec-0009"><label>2</label><title>Methods</title><p>This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for cross&#8208;sectional research (see Appendix&#160;<xref rid="dar70011-app-0001" ref-type="app">A</xref>) and received approval from the University of Wollongong Human Research Ethics Committee (2021/208).</p><sec id="dar70011-sec-0010"><label>2.1</label><title>Setting</title><p>Data for this study was collected from a not&#8208;for&#8208;profit organisation that provides treatment for up to 84 adults experiencing problematic alcohol or substance use. The residential program operates within a modified Therapeutic Community model, grounded in the &#8216;community as method&#8217; philosophy, which emphasises mutual self&#8208;help, structured routines and the use of the peer community to facilitate behavioural and psychological change [<xref rid="dar70011-bib-0030" ref-type="bibr">30</xref>, <xref rid="dar70011-bib-0031" ref-type="bibr">31</xref>]. This approach relies on a structured daily schedule and defined roles that support residents in developing accountability and emotional regulation through communal living [<xref rid="dar70011-bib-0032" ref-type="bibr">32</xref>]. The program accommodates men and women, and follows a stepped&#8208;care approach over a 9&#8211;12&#8201;months period. It offers integrated support for mental and physical health needs, including a withdrawal management unit, specialised therapy groups, the Residential College, individual and group counselling and access to specialised family support. While the organisation also delivers community&#8208;based programs, this study focuses exclusively on the residential treatment setting.</p></sec><sec id="dar70011-sec-0011"><label>2.2</label><title>Recruitment and Data Collection</title><p>Recruitment of participants for the current study involved collaboration between researchers and residential service staff. Residential clients were recruited on site, with data collection completed anonymously either online via Qualtrics or a paper survey which was later transferred to Qualtrics. Data was collected as part of broader routine quality improvement audits and followed a census approach, with data collected at a given point in time among residents available at the service during recruitment, rather than at a specific moment in individuals' treatment process. Data was collected in two waves: from July to August 2021, and July to November 2024. There were no significant changes in the structure of the program between the two time points.</p></sec><sec id="dar70011-sec-0012"><label>2.3</label><title>Participants</title><p>Inclusion criteria for the current study included being aged over 18, currently participating in residential treatment at the included not&#8208;for&#8208;profit service, and providing informed consent to participate. There were no exclusion criteria. A total of 138 clients completed the survey, including 43 (30.9%) women.</p></sec><sec id="dar70011-sec-0013"><label>2.4</label><title>Measures</title><p>
<italic toggle="yes">Demographics</italic>: Demographic items were adapted from the <italic toggle="yes">Your Experience of Service (YES)</italic> survey [<xref rid="dar70011-bib-0033" ref-type="bibr">33</xref>] and other Australian studies in residential AOD settings [<xref rid="dar70011-bib-0034" ref-type="bibr">34</xref>]. Demographic data was collected regarding participant's gender identity (man, woman, other), main language spoken at home (English, other), age (in years) and highest level of education (high school or less, TAFE/Trade, University). Substance of concern included six response options (alcohol, amphetamine, heroin, cannabis, cocaine and other). On the web&#8208;based survey, respondents were permitted to indicate only one response, whereas on the paper&#8208;based survey, multiple participants indicated more than one drug of concern. Data regarding the number and percentage of participants reporting any use (yes/no) of the six substance use options was assessed for descriptive purposes only. Questions were also asked regarding participant's length of current treatment episode (in weeks), and whether they had previously accessed treatment for their mental health (including whether a diagnosis was provided).</p><p>
<italic toggle="yes">Patient Reported Experience Measure for Addiction Treatment</italic> [<xref rid="dar70011-bib-0027" ref-type="bibr">27</xref>]. The PREMAT is a 23&#8208;item measure used to assess people's experiences of their current residential treatment episode. Items are scored on a Likert scale from 1 (&#8216;<italic toggle="yes">strongly disagree</italic>&#8217;) to 5 (&#8216;<italic toggle="yes">strongly agree</italic>&#8217;). Item scores are summed to produce a total score ranging from 23 to 115, with higher scores indicating greater levels of positive experience associated with treatment engagement. Scores can also be categorised into groups: poor experience (23&#8211;74), average experience (75&#8211;87), good experience (88&#8211;99) and very good experience (100&#8211;115) [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>]. PREMAT domain scores were calculated by summing responses to the relevant items for each of the six domains identified by Kelly et&#160;al. [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>]. These domains are: (i) individualised support (e.g., support, enough one&#8208;on&#8208;one sessions, help for difficulties and being treated like a person instead of an addict); (ii) self&#8208;determination and empowerment (e.g., increased awareness, improved self&#8208;perception, feeling understood and being able to cope with everyday life); (iii) program structure (e.g., structured days, schedules, opportunities to exercise and, time to focus on recovery); (iv) treatment environment (e.g., privacy, nutrition and cleanliness); (v) co&#8208;ordination of care (e.g., involvement of family and friends, being linked up with other services); and (vi) personal responsibility (e.g., knowing what the rules are and consequences for breaking rules). The PREMAT has been validated for use within residential AOD treatment services and shows good internal consistency, test&#8211;retest reliability and convergent validity [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>, <xref rid="dar70011-bib-0035" ref-type="bibr">35</xref>]. All PREMAT items, including their domain loading, are presented in Appendix&#160;<xref rid="dar70011-app-0002" ref-type="app">B</xref>.</p><p>
<italic toggle="yes">Client Satisfaction Questionnaire&#8208;8</italic> (CSQ&#8208;8; [<xref rid="dar70011-bib-0036" ref-type="bibr">36</xref>]). The CSQ&#8208;8 was developed as a brief measure of global satisfaction. Items are scored on a Likert scale from 1 (&#8216;<italic toggle="yes">low satisfaction</italic>&#8217;) to 4 (&#8216;<italic toggle="yes">high satisfaction</italic>&#8217;). Item scores are summed to produce a total score, ranging from 8 to 32, with higher total scores indicating greater satisfaction with care. The CSQ&#8208;8 has high internal consistency and concurrent validity in mental health outpatient settings [<xref rid="dar70011-bib-0037" ref-type="bibr">37</xref>] and has been validated for use within inpatient populations [<xref rid="dar70011-bib-0034" ref-type="bibr">34</xref>, <xref rid="dar70011-bib-0038" ref-type="bibr">38</xref>, <xref rid="dar70011-bib-0039" ref-type="bibr">39</xref>].</p></sec><sec id="dar70011-sec-0014"><label>2.5</label><title>Statistical Analysis</title><p>Descriptive statistics were used to examine the demographics of all participants who completed the survey, including Chi&#8208;square tests with Bonferroni correction and <italic toggle="yes">t</italic>&#8208;tests to examine proportional and mean differences between men and women. Among the 138 participants who completed the survey, 127 had complete PREMAT data. For individual PREMAT items, the item with the highest amount of missing data was item 22 (&#8216;I have been linked up with other services to support me when I leave this program&#8217;), with a 92.8% response rate. On a participant level, missing data ranged from 1 item to 10 items. Two participants missing three or fewer PREMAT item responses out of the 23 total items (i.e., &lt;&#8201;10% of total PREMAT items) had values for these items imputed based on the mean of their completed PREMAT items [<xref rid="dar70011-bib-0040" ref-type="bibr">40</xref>, <xref rid="dar70011-bib-0041" ref-type="bibr">41</xref>]. Participants missing more than three PREMAT item responses were excluded (<italic toggle="yes">n</italic>&#8201;=&#8201;9), resulting in a sample size of 129 for all PREMAT&#8208;related analyses. Due to non&#8208;normality of the data and unequal group sizes, Mann&#8211;Whitney <italic toggle="yes">U</italic> tests were used to examine median differences between men and women on PREMAT item, domain and total scores.</p><p>CSQ and PREMAT data was non&#8208;normally distributed and negatively skewed. Transformations (including reflection and log10, square root and Box&#8208;Cox) did not remedy the non&#8208;normality of the data. For more robust analysis of the non&#8208;normal data, a generalised linear model was used to determine the relationship between PREMAT domains and overall CSQ scores, including whether these relationships are moderated by gender. The model also controlled for age (in years) and length of current treatment episode (in weeks). Parameter estimates were obtained using maximum likelihood estimation. Goodness of fit statistics were examined to determine model fit, including log&#8208;likelihood, Akaike Information Criterion, Consistent Akaike Information Criterion and Bayesian Information Criterion. Coefficients for each predictor variable were assessed, with a significance level set at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05. The proposed model is presented in Appendix&#160;<xref rid="dar70011-app-0003" ref-type="app">C</xref>.</p><p>Relative importance analysis was conducted to assess the proportional contribution of each of the PREMAT domains to overall treatment satisfaction [<xref rid="dar70011-bib-0042" ref-type="bibr">42</xref>, <xref rid="dar70011-bib-0043" ref-type="bibr">43</xref>]. The relative weight statistic has been shown to provide robust estimates of the relative importance of predictor variables, particularly when those predictor variables are correlated [<xref rid="dar70011-bib-0043" ref-type="bibr">43</xref>]. This has been found in both simulation and primary studies [<xref rid="dar70011-bib-0044" ref-type="bibr">44</xref>, <xref rid="dar70011-bib-0045" ref-type="bibr">45</xref>]. The statistical assumptions and method are described elsewhere [<xref rid="dar70011-bib-0042" ref-type="bibr">42</xref>, <xref rid="dar70011-bib-0043" ref-type="bibr">43</xref>, <xref rid="dar70011-bib-0044" ref-type="bibr">44</xref>]. Tonidandel and LeBreton [<xref rid="dar70011-bib-0044" ref-type="bibr">44</xref>] developed an interactive website for conducting relative importance analysis that performs calculations using the open&#8208;source R statistical package as its backbone (<ext-link xlink:href="https://www.scotttonidandel.com/rwa-web" ext-link-type="uri">https://www.scotttonidandel.com/rwa&#8208;web</ext-link>). This free website was used to conduct the relative importance analysis, with CSQ total score entered as the outcome and PREMAT domain scores entered as predictors. As suggested, 10,000 bootstraps at a <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 level were utilised to obtain the raw relative weight for each predictor, which were then rescaled to relative weight percentages (indicating percentage in total possible variance (i.e., 100%) in total satisfaction that each predictor explains). This was calculated for the overall sample and then for men and women separately, with raw relative weights compared between men and women to assess gender differences.</p></sec></sec><sec sec-type="results" id="dar70011-sec-0015"><label>3</label><title>Results</title><sec id="dar70011-sec-0016"><label>3.1</label><title>Participant Demographics</title><p>Table&#160;<xref rid="dar70011-tbl-0001" ref-type="table">1</xref> shows participant characteristics (<italic toggle="yes">N</italic>&#8201;=&#8201;138). Participants had a mean age of 37.33 (SD&#8201;=&#8201;11.07) and treatment duration of 15.67&#8201;weeks (SD&#8201;=&#8201;18.64). Over one&#8208;third (64.7%) reported high school or less as their highest level of education, and almost 40% reported having received a mental health diagnosis in the past. The most commonly reported substance of concern was amphetamines (45.7%), followed by alcohol (37.2%). A significantly higher proportion of women reported amphetamine use compared to men (61.0% vs. 38.6%). More women reported a mental health diagnosis compared to men (58.1% vs. 29.5%), and women were more likely to report TAFE/Trade as their highest level of education (34.9% vs. 20.0%).</p><table-wrap position="float" id="dar70011-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Participant demographics (<italic toggle="no">N</italic>&#8201;=&#8201;138).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">Characteristic</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total sample (<italic toggle="yes">N</italic>&#8201;=&#8201;138)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Men (<italic toggle="yes">n</italic>&#8201;=&#8201;95)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Women (<italic toggle="yes">n</italic>&#8201;=&#8201;43)</th><th rowspan="2" align="center" valign="bottom" colspan="1">Difference <italic toggle="yes">&#967;</italic>
<sup>2</sup>/<italic toggle="yes">t</italic>, <italic toggle="yes">p</italic>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%) or <italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%) or <italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%) or <italic toggle="yes">M</italic> (SD)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">37.33 (11.07)</td><td align="center" valign="top" rowspan="1" colspan="1">37.80 (11.45)</td><td align="center" valign="top" rowspan="1" colspan="1">36.10 (10.26)</td><td align="center" valign="top" rowspan="1" colspan="1">0.804, <italic toggle="yes">p</italic>&#8201;=&#8201;0.423</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Highest education</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">High school or less</td><td align="center" valign="top" rowspan="1" colspan="1">90 (64.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">66 (69.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (55.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">6.494, <italic toggle="yes">p</italic>&#8201;=&#8201;0.165</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TAFE/trade</td><td align="center" valign="top" rowspan="1" colspan="1">25 (25.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (20.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>15 (34.9%)</bold>
<xref rid="dar70011-note-0005" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">University</td><td align="center" valign="top" rowspan="1" colspan="1">14 (10.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (10.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (9.3%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Length of treatment, weeks</td><td align="center" valign="top" rowspan="1" colspan="1">15.67 (18.64)</td><td align="center" valign="top" rowspan="1" colspan="1">17.22 (20.34)</td><td align="center" valign="top" rowspan="1" colspan="1">12.50 (14.25)</td><td align="center" valign="top" rowspan="1" colspan="1">1.317, <italic toggle="yes">p</italic>&#8201;=&#8201;0.190</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Substance of concern<xref rid="dar70011-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="center" valign="top" rowspan="1" colspan="1">48 (37.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">35 (39.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (31.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.779, <italic toggle="yes">p</italic>&#8201;=&#8201;0.378</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Amphetamines</td><td align="center" valign="top" rowspan="1" colspan="1">59 (45.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">34 (38.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>25 (61.0%)</bold>
<xref rid="dar70011-note-0005" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5.624, <italic toggle="yes">p</italic>
</bold>&#8201;=&#8201;<bold>0.018</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Heroin</td><td align="center" valign="top" rowspan="1" colspan="1">7 (5.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (8.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.448, <italic toggle="yes">p</italic>&#8201;=&#8201;0.063</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="center" valign="top" rowspan="1" colspan="1">10 (7.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (6.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.338, <italic toggle="yes">p</italic>&#8201;=&#8201;0.561</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cocaine</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (3.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.088, <italic toggle="yes">p</italic>&#8201;=&#8201;0.767</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other</td><td align="center" valign="top" rowspan="1" colspan="1">7 (5.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (5.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (4.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.035, <italic toggle="yes">p</italic>&#8201;=&#8201;0.851</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mental health diagnosis, yes</td><td align="center" valign="top" rowspan="1" colspan="1">54 (38.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">28 (29.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>25 (58.1%)</bold>
<xref rid="dar70011-note-0005" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>11.825, <italic toggle="yes">p</italic>
</bold>&#8201;=&#8201;<bold>0.003</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Satisfaction with treatment, CSQ total</td><td align="center" valign="top" rowspan="1" colspan="1">24.97 (5.01)</td><td align="center" valign="top" rowspan="1" colspan="1">24.95 (5.08)</td><td align="center" valign="top" rowspan="1" colspan="1">25.07 (4.97)</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.132, <italic toggle="yes">p</italic>&#8201;=&#8201;0.895</td></tr></tbody></table><table-wrap-foot id="dar70011-ntgp-0002"><fn id="dar70011-note-0003"><p>Abbreviations: CSQ, Client Satisfaction Questionnaire; TAFE, Technical and Further Education Institute Australia (vocational education and training).</p></fn><fn id="dar70011-note-0004"><label>
<sup>a</sup>
</label><p>
<italic toggle="yes">n</italic> and percentages do not equal <italic toggle="yes">N</italic> as multiple response options permitted.</p></fn><fn id="dar70011-note-0005"><label>
<sup>b</sup>
</label><p>Indicates higher proportion based on <italic toggle="yes">z</italic> test with Bonferroni correction (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, in bold) comparing male and female proportions on each level of each variable.</p></fn></table-wrap-foot></table-wrap></sec><sec id="dar70011-sec-0017"><label>3.2</label><title>Gender Differences <styled-content style="fixed-case" toggle="no">PREMAT</styled-content> Item, Domain and Total Scores</title><p>Among participants with valid PREMAT data (<italic toggle="yes">n</italic>&#8201;=&#8201;129), PREMAT total scores ranged from 42 to 115, with an average score of 90.33 (SD&#8201;=&#8201;16.13), indicating &#8216;good&#8217; experiences of treatment. There were no differences between men and women on any PREMAT domain score or total score (Table&#160;<xref rid="dar70011-tbl-0002" ref-type="table">2</xref>). There were no gender differences observed at the item level (Appendix&#160;<xref rid="dar70011-app-0002" ref-type="app">B</xref>). A strong negative skew was observed for PREMAT items, domain scores and total scores, indicating a clustering of high&#8208;score responses.</p><table-wrap position="float" id="dar70011-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>PREMAT domain total scores by gender (<italic toggle="no">N</italic>&#8201;=&#8201;129).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">PREMAT domain</th><th rowspan="2" align="center" valign="bottom" colspan="1">Score range<xref rid="dar70011-note-0007" ref-type="table-fn">
<sup>a</sup>
</xref>
</th><th colspan="2" align="center" valign="bottom" rowspan="1">Total (<italic toggle="yes">N</italic>&#8201;=&#8201;129)</th><th colspan="2" align="center" valign="bottom" rowspan="1">Men (<italic toggle="yes">n</italic>&#8201;=&#8201;88)</th><th colspan="2" align="center" valign="bottom" rowspan="1">Women (<italic toggle="yes">n</italic>&#8201;=&#8201;41)</th><th rowspan="2" align="center" valign="bottom" colspan="1">Difference <italic toggle="yes">U</italic>, <italic toggle="yes">p</italic>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Median [IQR]</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Median [IQR]</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Median [IQR]</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Individualised support</td><td align="center" valign="top" rowspan="1" colspan="1">5&#8211;25</td><td align="center" valign="top" rowspan="1" colspan="1">19.21 (4.02)</td><td align="center" valign="top" rowspan="1" colspan="1">19 [4.50]</td><td align="center" valign="top" rowspan="1" colspan="1">19.33 (3.76)</td><td align="center" valign="top" rowspan="1" colspan="1">20 [4.00]</td><td align="center" valign="top" rowspan="1" colspan="1">19.17 (4.58)</td><td align="center" valign="top" rowspan="1" colspan="1">19 [8.50]</td><td align="center" valign="top" rowspan="1" colspan="1">0.586, <italic toggle="yes">p</italic>&#8201;=&#8201;0.444</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self&#8208;determination and empowerment</td><td align="center" valign="top" rowspan="1" colspan="1">5&#8211;25</td><td align="center" valign="top" rowspan="1" colspan="1">20.30 (3.68)</td><td align="center" valign="top" rowspan="1" colspan="1">20 [4.67]</td><td align="center" valign="top" rowspan="1" colspan="1">20.49 (3.30)</td><td align="center" valign="top" rowspan="1" colspan="1">20 [4.00]</td><td align="center" valign="top" rowspan="1" colspan="1">19.92 (4.40)</td><td align="center" valign="top" rowspan="1" colspan="1">20 [6.0]</td><td align="center" valign="top" rowspan="1" colspan="1">0.210, <italic toggle="yes">p</italic>&#8201;=&#8201;0.647</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Program structure</td><td align="center" valign="top" rowspan="1" colspan="1">4&#8211;20</td><td align="center" valign="top" rowspan="1" colspan="1">16.87 (2.65)</td><td align="center" valign="top" rowspan="1" colspan="1">17 [4.00]</td><td align="center" valign="top" rowspan="1" colspan="1">16.85 (2.43)</td><td align="center" valign="top" rowspan="1" colspan="1">16 [3.00]</td><td align="center" valign="top" rowspan="1" colspan="1">16.90 (3.10)</td><td align="center" valign="top" rowspan="1" colspan="1">18 [5.0]</td><td align="center" valign="top" rowspan="1" colspan="1">1.206, <italic toggle="yes">p</italic>&#8201;=&#8201;0.272</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment environment</td><td align="center" valign="top" rowspan="1" colspan="1">4&#8211;20</td><td align="center" valign="top" rowspan="1" colspan="1">15.05 (3.35)</td><td align="center" valign="top" rowspan="1" colspan="1">16 [5.50]</td><td align="center" valign="top" rowspan="1" colspan="1">15.16 (3.24)</td><td align="center" valign="top" rowspan="1" colspan="1">16 [4.00]</td><td align="center" valign="top" rowspan="1" colspan="1">14.80 (3.59)</td><td align="center" valign="top" rowspan="1" colspan="1">14 [6.50]</td><td align="center" valign="top" rowspan="1" colspan="1">0.269, <italic toggle="yes">p</italic>&#8201;=&#8201;0.604</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coordination of care</td><td align="center" valign="top" rowspan="1" colspan="1">3&#8211;15</td><td align="center" valign="top" rowspan="1" colspan="1">10.63 (3.13)</td><td align="center" valign="top" rowspan="1" colspan="1">11 [4.02]</td><td align="center" valign="top" rowspan="1" colspan="1">10.80 (2.91)</td><td align="center" valign="top" rowspan="1" colspan="1">11.07 [3.00]</td><td align="center" valign="top" rowspan="1" colspan="1">10.26 (3.56)</td><td align="center" valign="top" rowspan="1" colspan="1">11 [5.50]</td><td align="center" valign="top" rowspan="1" colspan="1">0.017, <italic toggle="yes">p</italic>&#8201;=&#8201;0.897</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Personal responsibility</td><td align="center" valign="top" rowspan="1" colspan="1">2&#8211;10</td><td align="center" valign="top" rowspan="1" colspan="1">8.20 (1.50)</td><td align="center" valign="top" rowspan="1" colspan="1">8 [3.00]</td><td align="center" valign="top" rowspan="1" colspan="1">8.17 (1.43)</td><td align="center" valign="top" rowspan="1" colspan="1">8 [1.00]</td><td align="center" valign="top" rowspan="1" colspan="1">8.26 (1.66)</td><td align="center" valign="top" rowspan="1" colspan="1">8 [3.00]</td><td align="center" valign="top" rowspan="1" colspan="1">2.149, <italic toggle="yes">p</italic>&#8201;=&#8201;0.143</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PREMAT total score</td><td align="center" valign="top" rowspan="1" colspan="1">23&#8211;115</td><td align="center" valign="top" rowspan="1" colspan="1">90.25 (16.09)</td><td align="center" valign="top" rowspan="1" colspan="1">90.1 [22.0]</td><td align="center" valign="top" rowspan="1" colspan="1">90.81 (14.87)</td><td align="center" valign="top" rowspan="1" colspan="1">91.5 [16.1]</td><td align="center" valign="top" rowspan="1" colspan="1">89.33 (19.71)</td><td align="center" valign="top" rowspan="1" colspan="1">91.0 [30.0]</td><td align="center" valign="top" rowspan="1" colspan="1">0.107, <italic toggle="yes">p</italic>&#8208;0.897</td></tr></tbody></table><table-wrap-foot id="dar70011-ntgp-0003"><fn id="dar70011-note-0006"><p>Abbreviations: IQR, interquartile range; PREMAT, Patient Reported Experience Measure for Addiction Treatment.</p></fn><fn id="dar70011-note-0007"><label>
<sup>a</sup>
</label><p>Items rated from 1 to 5. Number of items in each domain: individualised support&#8201;=&#8201;5, self&#8208;determination and empowerment&#8201;=&#8201;5, program structure&#8201;=&#8201;4, treatment environment&#8201;=&#8201;4, coordination of care&#8201;=&#8201;3, personal responsibility&#8201;=&#8201;2.</p></fn></table-wrap-foot></table-wrap></sec><sec id="dar70011-sec-0018"><label>3.3</label><title>Associations Between <styled-content style="fixed-case" toggle="no">PREMAT</styled-content> Domains and Overall Treatment Satisfaction</title><p>A generalised linear model was conducted to determine the predictive relationship between PREMAT domains and overall treatment satisfaction (CSQ total score), including the interaction between PREMAT domains and gender, controlling for age and weeks in treatment. The addition of the predictors (i.e., gender, age, weeks in treatment, each of the six PREMAT domains, interaction between gender and each domain) significantly improved the model compared to the intercept&#8208;only model (likelihood ratio chi&#8208;square&#8201;=&#8201;129.15, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) with improved goodness of fit indicators. A test of model effects indicated that, controlling for age (<italic toggle="yes">p</italic>&#8201;=&#8201;0.469) and length of treatment (<italic toggle="yes">p</italic>&#8201;=&#8201;0.383), significant predictors of overall treatment satisfaction (total CSQ score) included self&#8208;determination and empowerment (Wald&#8201;=&#8201;18.833, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), personal responsibility (Wald&#8201;=&#8201;8.258, <italic toggle="yes">p</italic>&#8201;=&#8201;0.004) and the interaction term between gender and personal responsibility (Wald&#8201;=&#8201;5.419, <italic toggle="yes">p</italic>&#8201;=&#8201;0.020).</p><p>Table&#160;<xref rid="dar70011-tbl-0003" ref-type="table">3</xref> shows the parameter estimates of the final model, adjusted for age and length of treatment. For every 1&#8208;point increase in total self&#8208;determination and empowerment domain score, there is an estimated 0.6&#8208;point increase in total satisfaction, or a relative increase of 2.5% (CSQ range 9&#8211;32, <italic toggle="yes">B</italic>&#8201;=&#8201;0.601, <italic toggle="yes">p</italic>&#8201;=&#8201;0.003). Similarly, every 1&#8208;point increase in total personal responsibility domain score is associated with an estimated 1.5&#8208;point increase in total satisfaction, a relative increase of 6.4% (<italic toggle="yes">B</italic>&#8201;=&#8201;1.523, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). There was also a significant interaction effect of gender on the relationship between personal responsibility and treatment satisfaction, indicating that the effect of personal responsibility on overall treatment satisfaction is weaker for women compared to men (<italic toggle="yes">B</italic>&#8201;=&#8201;&#8722;1.380, <italic toggle="yes">p</italic>&#8201;=&#8201;0.020).</p><table-wrap position="float" id="dar70011-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Parameter estimates of generalised linear model predicting overall treatment satisfaction, controlling for age and weeks in treatment.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Predictor</th><th align="center" valign="bottom" rowspan="1" colspan="1">ADJ <italic toggle="yes">B</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">[95% CI <italic toggle="yes">B</italic>]</th><th align="center" valign="bottom" rowspan="1" colspan="1">Wald chi&#8208;square</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sig.</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (woman)</td><td align="center" valign="top" rowspan="1" colspan="1">5.657</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;1.328, 12.643]</td><td align="center" valign="top" rowspan="1" colspan="1">2.530</td><td align="center" valign="top" rowspan="1" colspan="1">0.112</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Individualised support</td><td align="center" valign="top" rowspan="1" colspan="1">0.058</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.355, 0.471]</td><td align="center" valign="top" rowspan="1" colspan="1">0.075</td><td align="center" valign="top" rowspan="1" colspan="1">0.784</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self&#8208;determination and empowerment</td><td align="center" valign="top" rowspan="1" colspan="1">0.601</td><td align="center" valign="top" rowspan="1" colspan="1">[0.209, 0.993]</td><td align="center" valign="top" rowspan="1" colspan="1">9.002</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.003</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Program structure</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.029</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.556, 0.498]</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td align="center" valign="top" rowspan="1" colspan="1">0.914</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment environment</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.157</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.491, 0.177]</td><td align="center" valign="top" rowspan="1" colspan="1">0.851</td><td align="center" valign="top" rowspan="1" colspan="1">0.356</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coordination of care</td><td align="center" valign="top" rowspan="1" colspan="1">0.060</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.318, 0.439]</td><td align="center" valign="top" rowspan="1" colspan="1">0.098</td><td align="center" valign="top" rowspan="1" colspan="1">0.755</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Personal responsibility</td><td align="center" valign="top" rowspan="1" colspan="1">1.523</td><td align="center" valign="top" rowspan="1" colspan="1">[0.744, 2.303]</td><td align="center" valign="top" rowspan="1" colspan="1">14.684</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Woman&#8201;*&#8201;Individualised support</td><td align="center" valign="top" rowspan="1" colspan="1">0.427</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.233, 1.087]</td><td align="center" valign="top" rowspan="1" colspan="1">1.608</td><td align="center" valign="top" rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Woman&#8201;*&#8201;Self&#8208;determination and empowerment</td><td align="center" valign="top" rowspan="1" colspan="1">0.211</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.403, 0.824]</td><td align="center" valign="top" rowspan="1" colspan="1">0.454</td><td align="center" valign="top" rowspan="1" colspan="1">0.501</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Woman&#8201;*&#8201;Program structure</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.240</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;1.043, 0.563]</td><td align="center" valign="top" rowspan="1" colspan="1">0.423</td><td align="center" valign="top" rowspan="1" colspan="1">0.559</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Woman&#8201;*&#8201;Treatment environment</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.084</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.641, 0.472]</td><td align="center" valign="top" rowspan="1" colspan="1">0.088</td><td align="center" valign="top" rowspan="1" colspan="1">0.766</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Woman&#8201;*&#8201;Coordination of care</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.109</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.709, 0.492]</td><td align="center" valign="top" rowspan="1" colspan="1">0.126</td><td align="center" valign="top" rowspan="1" colspan="1">0.723</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Woman&#8201;*&#8201;Personal responsibility</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;1.380</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;2.542, &#8722;0.218]</td><td align="center" valign="top" rowspan="1" colspan="1">5.419</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.020</bold>
</td></tr></tbody></table><table-wrap-foot id="dar70011-ntgp-0004"><fn id="dar70011-note-0101"><p>
<italic toggle="yes">Note</italic>: Bold indicates the significant values.</p></fn><fn id="dar70011-note-0008"><p>Abbreviation: CI, confidence interval.</p></fn></table-wrap-foot></table-wrap><p>Relative importance analysis confirmed these results, indicating a significant difference in the relative importance/weight of personal responsibility on overall satisfaction for men compared to women, where personal responsibility explained 26.7% of the total possible variance in treatment satisfaction for men, compared to 7.5% for women (Table&#160;<xref rid="dar70011-tbl-0004" ref-type="table">4</xref>). Overall, the PREMAT domains explained 64.8% of the variance in overall treatment satisfaction.</p><table-wrap position="float" id="dar70011-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>Relative importance analysis of patient reported experience measure for addiction treatment domains to overall treatment satisfaction.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">Predictor</th><th rowspan="2" align="center" valign="bottom" colspan="1">Raw relative weight [95% CI]</th><th colspan="3" align="center" valign="bottom" rowspan="1">Rescaled relative weight (%)</th><th rowspan="2" align="center" valign="bottom" colspan="1">Group comparison [95% CI]</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">Total</th><th align="center" valign="bottom" rowspan="1" colspan="1">Men</th><th align="center" valign="bottom" rowspan="1" colspan="1">Women</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Individualised support</td><td align="center" valign="top" rowspan="1" colspan="1">0.12 [0.07, 0.18]</td><td align="center" valign="top" rowspan="1" colspan="1">18.49</td><td align="center" valign="top" rowspan="1" colspan="1">16.12</td><td align="center" valign="top" rowspan="1" colspan="1">21.46</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.15, 0.06]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self&#8208;determination and empowerment</td><td align="center" valign="top" rowspan="1" colspan="1">0.18 [0.13, 0.26]</td><td align="center" valign="top" rowspan="1" colspan="1">27.69</td><td align="center" valign="top" rowspan="1" colspan="1">24.86</td><td align="center" valign="top" rowspan="1" colspan="1">19.53</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.17, 0.06]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Program structure</td><td align="center" valign="top" rowspan="1" colspan="1">0.10 [0.07, 0.14]</td><td align="center" valign="top" rowspan="1" colspan="1">16.08</td><td align="center" valign="top" rowspan="1" colspan="1">16.25</td><td align="center" valign="top" rowspan="1" colspan="1">15.49</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.08, 0.06]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment environment</td><td align="center" valign="top" rowspan="1" colspan="1">0.03 [0.02, 0.09]</td><td align="center" valign="top" rowspan="1" colspan="1">9.32</td><td align="center" valign="top" rowspan="1" colspan="1">7.99</td><td align="center" valign="top" rowspan="1" colspan="1">11.9</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.10, 0.03]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coordination of care</td><td align="center" valign="top" rowspan="1" colspan="1">0.06 [0.03, 0.10]</td><td align="center" valign="top" rowspan="1" colspan="1">9.95</td><td align="center" valign="top" rowspan="1" colspan="1">8.10</td><td align="center" valign="top" rowspan="1" colspan="1">14.06</td><td align="center" valign="top" rowspan="1" colspan="1">[&#8722;0.14, 0.02]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Personal responsibility</td><td align="center" valign="top" rowspan="1" colspan="1">0.12 [0.07, 0.18]</td><td align="center" valign="top" rowspan="1" colspan="1">18.47</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>26.68</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7.51</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>[0.03, 0.23]</bold>
</td></tr></tbody></table><table-wrap-foot id="dar70011-ntgp-0005"><fn id="dar70011-note-0009"><p>Abbreviation: CI, confidence interval.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="dar70011-sec-0019"><label>4</label><title>Discussion</title><p>Research has demonstrated that the under&#8208;utilisation of PREMs in AOD research and treatment contributes to a situation where women's experiences are not properly understood, or where their satisfaction with treatment is over&#8208;stated [<xref rid="dar70011-bib-0024" ref-type="bibr">24</xref>, <xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. This is particularly evident when women's overall satisfaction scores obtained using PREMs are compared with qualitative or mixed&#8208;methods research regarding women's experiences of treatment [<xref rid="dar70011-bib-0024" ref-type="bibr">24</xref>, <xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. However, PREMs provide the opportunity to examine specific aspects of clients' experiences, how these experiences inform and impact their overall satisfaction and engagement with treatment, and whether these relationships are gender specific. Given the relationship between treatment satisfaction and treatment retention and outcomes [<xref rid="dar70011-bib-0046" ref-type="bibr">46</xref>, <xref rid="dar70011-bib-0047" ref-type="bibr">47</xref>, <xref rid="dar70011-bib-0048" ref-type="bibr">48</xref>, <xref rid="dar70011-bib-0049" ref-type="bibr">49</xref>, <xref rid="dar70011-bib-0050" ref-type="bibr">50</xref>], understanding and improving client experiences shown to impact overall satisfaction is an important priority for residential services, and will also aid in advancing person&#8208;centred care approaches across the residential treatment sector.</p><p>Results of the current study demonstrated that the PREMAT domain of &#8216;self&#8208;determination and empowerment&#8217; is a significant predictor of overall treatment satisfaction, regardless of gender. Experiences related to increased awareness and understanding of AOD use, involvement in care planning, feeling supported by staff and other residents and being supported to cope with everyday life, emerged as more important to overall treatment satisfaction than treatment or process&#8208;based experiences like the structure of the program, schedules, privacy or physical aspects of the environment. It is recognised that the implementation of some of these practices within routine service delivery may be challenging, particularly within a field where disempowerment, distrust and stigma can be common [<xref rid="dar70011-bib-0008" ref-type="bibr">8</xref>, <xref rid="dar70011-bib-0051" ref-type="bibr">51</xref>, <xref rid="dar70011-bib-0052" ref-type="bibr">52</xref>], and where time, financial and resource constraints may impact the degree of client involvement [<xref rid="dar70011-bib-0053" ref-type="bibr">53</xref>, <xref rid="dar70011-bib-0054" ref-type="bibr">54</xref>]. Despite challenges in designing and delivering treatment to clients with diverse and distinct needs, particularly women [<xref rid="dar70011-bib-0055" ref-type="bibr">55</xref>], clinical standards and a commitment to person&#8208;centred care warrant individualised care planning and collaborative decision making throughout all stages of treatment [<xref rid="dar70011-bib-0056" ref-type="bibr">56</xref>]. For women, fostering knowledge of personal and social identities, awareness of gender&#8208;role stereotypes and oppression, expression of traditional feminine characteristics and awareness of unequal power statuses, may also play important roles in increasing self&#8208;empowerment [<xref rid="dar70011-bib-0057" ref-type="bibr">57</xref>, <xref rid="dar70011-bib-0058" ref-type="bibr">58</xref>]. This is particularly important given the historically patriarchal nature of AOD treatment, as well as historical approaches to AOD treatment that include shame&#8208;based practices, moralistic frameworks and religious influences, which may have been particularly exclusionary or punitive towards women [<xref rid="dar70011-bib-0012" ref-type="bibr">12</xref>].</p><p>The current results also demonstrated that personal responsibility has a weaker impact on overall treatment satisfaction for women, compared to men. This domain focuses on the rules of the treatment program&#8212;whether the rules are sensible, clearly communicated and have clear consequences if not met. These results may be interpreted in the context of women's socialisation, societal expectations and gender roles, where women are often more concerned with social harmony, maintaining order and group cohesion, resulting in greater adherence to established rules and norms within society [<xref rid="dar70011-bib-0059" ref-type="bibr">59</xref>]. As such, entering a residential treatment setting with structured rules and consequences for not adhering to such rules may not be a new or unique experience for women, and consequently, may not influence their overall treatment satisfaction as much as for men. While this is speculative and represents an important area for further research, these results highlight the importance of reasonable rules that are clearly communicated, particularly for men within a residential, therapeutic community setting. Further research should consider whether this is similar for men participating in other models of care and explore potential explanations for this gendered relationship between personal responsibility and treatment satisfaction.</p><p>Women in the current study reported high satisfaction with treatment across all PREMAT domains. Satisfaction scores provide useful information regarding the overall satisfaction of clients engaged in treatment. However, the focus on individual experiences that PREMs afford can directly inform service provisions and improvements based on an identification of experiences that may be amenable to change [<xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. While our research had no qualitative component, parallels can also be drawn between the general misalignment of quantitative satisfaction results and qualitative experience findings for women [<xref rid="dar70011-bib-0024" ref-type="bibr">24</xref>, <xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. The PREMAT was developed in consultation with men and women engaged in residential treatment services. However, all suggestions and considerations were combined into a single measure [<xref rid="dar70011-bib-0027" ref-type="bibr">27</xref>]. The current results demonstrate that the PREMAT captures some treatment experiences that are salient for both men and women. However, it may be that the PREMAT, and other measures of satisfaction/experience, are lacking in consideration of gendered experience or experiences that may be specific to women, for example, heightened experience of stigma due to being a woman who uses substances, gendered interactions with staff, operational or logistical considerations for women with children and/or families, considerations regarding pregnancy and access to female specific services or care within a treatment setting [<xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. Consistent with centring lived and living experience in research and treatment, qualitative methods can capture the complexity and nuances of women's experiences of treatment. However, the time and resource intensity of qualitative methods may render them less feasible in a clinical, service delivery setting [<xref rid="dar70011-bib-0060" ref-type="bibr">60</xref>]. The development of women&#8208;specific measures that address gendered issues and experiences that are more relevant to women may allow for a quicker understanding of a service's ability to meet women's needs [<xref rid="dar70011-bib-0025" ref-type="bibr">25</xref>]. On a larger scale, such measures may play an important role in benchmarking and progress monitoring [<xref rid="dar70011-bib-0061" ref-type="bibr">61</xref>], which may influence service development and improvements for women across the residential AOD treatment sector. In addition, the PREMAT domains explained around 65% of the variance in overall treatment satisfaction, indicating that there are other factors or experiences that may play an important role in informing client's satisfaction with treatment that are not captured by the PREMAT, for both men and women.</p><p>The current study had several strengths and limitations. Strengths of this study include the use of validated measures of satisfaction/experience for residential services, including the relatively novel PREMAT measure, specifically developed with men and women engaged in residential treatment, although there is potential for improved gender&#8208;specificity. The study also utilised robust methods to address an identified gap in current PREM research, specifically analysing the relationships between client experiences and overall treatment satisfaction within a single treatment episode at a given point in time. However, recruiting from a single service limits the generalisability of findings to clients accessing different services. The census approach to data collection may also limit the reliability of the findings, as data was collected at a certain point in time rather than focusing on the specific stages of treatment or recovery of each participant. Future research may consider how being in different stages of treatment impacts clients' experiences of care. There was also limited variability in PREMAT domain scores and overall satisfaction scores were high, which is quite common in AOD treatment settings [<xref rid="dar70011-bib-0024" ref-type="bibr">24</xref>, <xref rid="dar70011-bib-0062" ref-type="bibr">62</xref>]. Although this research was led externally, data were collected anonymously and clients were free to decline participation, it is possible clients responded in a socially desirable manner. It is possible that clients may have been unwilling to speak of negative experiences, or exaggerated their satisfaction, due to difficulties in accessing treatment (e.g., due to disparities in treatment demand vs. treatment places, long waitlists, etc.). This may also be influenced by factors such as parenting concerns, fear of child removal or family restoration concerns and access to family&#8208;inclusive services, which may shape women's experiences of treatment and contribute to the positive&#8208;leaning nature of the data. Future research should consider examining these additional factors to better understand their impact on treatment engagement and reported treatment satisfaction. Results may also be subject to selection bias as participants had been in treatment for an average of over 15&#8201;weeks. Clients who left treatment prior to data collection, or opted not to participate, may have had different experiences. Finally, the substance of concern variable should be interpreted with caution, with the number of clients reporting substances of concern likely being under&#8208;represented due to inconsistencies in web&#8208;based versus paper&#8208;based survey collection.</p></sec><sec sec-type="conclusions" id="dar70011-sec-0020"><label>5</label><title>Conclusion</title><p>Patient&#8208;reported experience measures are a valuable tool in advancing and committing to person&#8208;centred care and provide opportunities to examine specific client experiences which impact overall treatment satisfaction. The development of PREMs which are more applicable to women may allow for quicker and more effective assessment of women's experiences of treatment. Further research should be conducted regarding the potential of PREMs (whether existing or newly developed) to identify gendered experiences of treatment across the residential AOD sector. Increasing individualised care and support and fostering self&#8208;determination, empowerment and personal responsibility for care are important aspects of residential treatment for both men and women.</p></sec><sec id="dar70011-sec-0022"><title>Author Contributions</title><p>
<bold>Chloe J. Haynes:</bold> conceptualisation, methodology, formal analysis, investigation, data curation, writing &#8211; original draft, writing &#8211; review and editing, visualisation, project administration. <bold>Alison K. Beck:</bold> conceptualisation, methodology, writing &#8211; review and editing, supervision. <bold>Peter J. Kelly:</bold> methodology, writing &#8211; review and editing, supervision. <bold>Dennis Kaip:</bold> writing &#8211; review and editing. <bold>Megan Wells:</bold> conceptualisation, methodology, investigation, data curation, writing&#160;&#8211; review and editing. <bold>Jaymee Issa:</bold> conceptualisation, methodology, investigation, data curation, writing &#8211; review and editing. <bold>David Kelly:</bold> writing&#160;&#8211; review and editing. <bold>Leanne Hides:</bold> writing &#8211; review and editing. <bold>Briony Larance:</bold> conceptualisation, methodology, writing &#8211; review and editing, supervision.</p></sec><sec sec-type="COI-statement" id="dar70011-sec-0023"><title>Conflicts of Interest</title><p>Chloe J. Haynes reports financial support was provided by Australian Government Research Training Program. Dennis Kaip and David Kelly report a relationship with Odyssey House that includes employment. The other authors declare no conflicts of interest.</p></sec></body><back><ack id="dar70011-sec-0021"><title>Acknowledgements</title><p>Chloe J. Haynes was supported by an Australian Government Research Training Program scholarship while conducting the research. This work was also supported by the National Health and Medical Research Council Meaningful Outcomes in Substance Use Treatment Centre of Research Excellence. The authors acknowledge all staff and clinicians at Odyssey House for their support of this research and all clients who provided data. Open access publishing facilitated by University of Wollongong, as part of the Wiley &#8208; University of Wollongong agreement via the Council of Australian University Librarians [Correction added on 28 August 2025, after first online publication: CAUL funding statement has been added].</p></ack><sec sec-type="data-availability" id="dar70011-sec-0025"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="dar70011-bibl-0001"><title>References</title><ref id="dar70011-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="dar70011-cit-0001"><string-name name-style="western"><given-names>J.</given-names><surname>Shen</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Hua</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Liu</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Liu</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Jiao</surname></string-name>, &#8220;<article-title>Prevalence, Incidence, Deaths, and Disability&#8208;Adjusted Life&#8208;Years of Drug Use Disorders for 204 Countries and Territories During the Past 30&#8201;Years</article-title>,&#8221; <source>Asian Journal of Psychiatry</source><volume>86</volume> (<year>2023</year>): <elocation-id>103677</elocation-id>.<pub-id pub-id-type="pmid">37348194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajp.2023.103677</pub-id></mixed-citation></ref><ref id="dar70011-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="dar70011-cit-0002"><string-name name-style="western"><given-names>L.</given-names><surname>Degenhardt</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Charlson</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Ferrari</surname></string-name>, et&#160;al., &#8220;<article-title>The Global Burden of Disease Attributable to Alcohol and Drug Use in 195 Countries and Territories, 1990&#8211;2013; 2016: A Systematic Analysis for the Global Burden of Disease Study 2016</article-title>,&#8221; <source>Lancet Psychiatry</source><volume>5</volume>, no. <issue>12</issue> (<year>2018</year>): <fpage>987</fpage>&#8211;<lpage>1012</lpage>.<pub-id pub-id-type="pmid">30392731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2215-0366(18)30337-7</pub-id><pub-id pub-id-type="pmcid">PMC6251968</pub-id></mixed-citation></ref><ref id="dar70011-bib-0003"><label>3</label><mixed-citation publication-type="book" id="dar70011-cit-0003"><collab collab-type="authors">United Nations Office on Drugs and Crime</collab>
, <source>World Drug Report 2023</source> (<publisher-name>United Nations Office on Drugs and Crime</publisher-name>, <year>2023</year>).</mixed-citation></ref><ref id="dar70011-bib-0004"><label>4</label><mixed-citation publication-type="book" id="dar70011-cit-0004"><collab collab-type="authors">Network of Alcohol and Other Drug Agencies</collab>
, <source>NADA Practice Guide: Providing Alcohol and Other Drug Treatment in a Residential Setting</source> (<publisher-name>Network of Alcohol and Other Drug Agencies</publisher-name>, <year>2022</year>).</mixed-citation></ref><ref id="dar70011-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="dar70011-cit-0005"><string-name name-style="western"><given-names>D.</given-names><surname>de Andrade</surname></string-name>, <string-name name-style="western"><given-names>R. A.</given-names><surname>Elphinston</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Quinn</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Allan</surname></string-name>, and <string-name name-style="western"><given-names>L.</given-names><surname>Hides</surname></string-name>, &#8220;<article-title>The Effectiveness of Residential Treatment Services for Individuals With Substance Use Disorders: A Systematic Review</article-title>,&#8221; <source>Drug and Alcohol Dependence</source><volume>201</volume> (<year>2019</year>): <fpage>227</fpage>&#8211;<lpage>235</lpage>.<pub-id pub-id-type="pmid">31254749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2019.03.031</pub-id></mixed-citation></ref><ref id="dar70011-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="dar70011-cit-0006"><string-name name-style="western"><given-names>S.</given-names><surname>Reif</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>George</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Braude</surname></string-name>, et&#160;al., &#8220;<article-title>Residential Treatment for Individuals With Substance Use Disorders: Assessing the Evidence</article-title>,&#8221; <source>Psychiatric Services</source><volume>65</volume>, no. <issue>3</issue> (<year>2014</year>): <fpage>301</fpage>&#8211;<lpage>312</lpage>.<pub-id pub-id-type="pmid">24445598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ps.201300242</pub-id></mixed-citation></ref><ref id="dar70011-bib-0007"><label>7</label><mixed-citation publication-type="miscellaneous" id="dar70011-cit-0007"><string-name name-style="western"><given-names>C.</given-names><surname>Gray</surname></string-name> and <string-name name-style="western"><given-names>C.</given-names><surname>Argaez</surname></string-name>, <article-title>&#8220;Residential Treatment for Substance Use Disorder: A Review of Clinical Effectiveness,&#8221; 2019</article-title>.<pub-id pub-id-type="pmid">31107598</pub-id></mixed-citation></ref><ref id="dar70011-bib-0008"><label>8</label><mixed-citation publication-type="book" id="dar70011-cit-0008"><collab collab-type="authors">Australian Commission on Safety and Quality in Health Care</collab>
, <source>Patient&#8208;Centred Care: Improving Quality and Safety Through Partnerships With Patients and Consumers</source> (<publisher-name>Australian Commission on Safety and Quality in Health Care</publisher-name>, <year>2011</year>).</mixed-citation></ref><ref id="dar70011-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="dar70011-cit-0009"><string-name name-style="western"><given-names>A.</given-names><surname>Coulter</surname></string-name> and <string-name name-style="western"><given-names>J.</given-names><surname>Oldham</surname></string-name>, &#8220;<article-title>Person&#8208;Centred Care: What Is It and How Do We Get There?</article-title>,&#8221; <source>Future Hospital Journal</source><volume>3</volume>, no. <issue>2</issue> (<year>2016</year>): <fpage>114</fpage>&#8211;<lpage>116</lpage>.<pub-id pub-id-type="pmid">31098200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7861/futurehosp.3-2-114</pub-id><pub-id pub-id-type="pmcid">PMC6465833</pub-id></mixed-citation></ref><ref id="dar70011-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="dar70011-cit-0010"><string-name name-style="western"><given-names>A.</given-names><surname>Madden</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Hopwood</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Neale</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Treloar</surname></string-name>, &#8220;<article-title>Beyond Cure: Patient Reported Outcomes of Hepatitis C Treatment Among People Who Inject Drugs in Australia</article-title>,&#8221; <source>Harm Reduction Journal</source><volume>15</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>1</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30111327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12954-018-0248-4</pub-id><pub-id pub-id-type="pmcid">PMC6094926</pub-id></mixed-citation></ref><ref id="dar70011-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="dar70011-cit-0011"><string-name name-style="western"><given-names>J.</given-names><surname>Rance</surname></string-name> and <string-name name-style="western"><given-names>C.</given-names><surname>Treloar</surname></string-name>, &#8220;&#8220;<article-title>We Are People Too&#8221;: Consumer Participation and the Potential Transformation of Therapeutic Relations Within Drug Treatment</article-title>,&#8221; <source>International Journal on Drug Policy</source><volume>26</volume>, no. <issue>1</issue> (<year>2015</year>): <fpage>30</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">24951024</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2014.05.002</pub-id></mixed-citation></ref><ref id="dar70011-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="dar70011-cit-0012"><string-name name-style="western"><given-names>B.</given-names><surname>Ettorre</surname></string-name>, &#8220;<article-title>Women and Substance Use/Abuse: Towards a Feminist Perspective or How to Make Dust Fly</article-title>,&#8221; <source>Women's Studies International Forum</source><volume>12</volume>, no. <issue>6</issue> (<year>1989</year>): <fpage>593</fpage>&#8211;<lpage>602</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="dar70011-cit-0013"><string-name name-style="western"><given-names>S. S.</given-names><surname>Covington</surname></string-name>, &#8220;<article-title>Women and Addiction: A Trauma&#8208;Informed Approach</article-title>,&#8221; <source>Journal of Psychoactive Drugs</source><volume>40</volume>, no. <issue>sup5</issue> (<year>2008</year>): <fpage>377</fpage>&#8211;<lpage>385</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/02791072.2008.10400665</pub-id><pub-id pub-id-type="pmid">19248395</pub-id></mixed-citation></ref><ref id="dar70011-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="dar70011-cit-0014"><string-name name-style="western"><given-names>L.</given-names><surname>Stanley</surname></string-name> and <string-name name-style="western"><given-names>S.</given-names><surname>Wise</surname></string-name>, <article-title>&#8220;Breaking Out: Feminist Consciousness and Feminist Research,&#8221; 1983</article-title>.</mixed-citation></ref><ref id="dar70011-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="dar70011-cit-0015"><string-name name-style="western"><given-names>E. R.</given-names><surname>Macleod</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Tajbakhsh</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Hamilton&#8208;Wright</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Laliberte</surname></string-name>, <string-name name-style="western"><given-names>J. L.</given-names><surname>Wiese</surname></string-name>, and <string-name name-style="western"><given-names>F. I.</given-names><surname>Matheson</surname></string-name>, &#8220;&#8220;<article-title>They're Not Doing Enough&#8221;: Women's Experiences With Opioids and Naloxone in Toronto</article-title>,&#8221; <source>Substance Abuse Treatment, Prevention, and Policy</source><volume>16</volume>, no. <issue>1</issue> (<year>2021</year>): <elocation-id>26</elocation-id>.<pub-id pub-id-type="pmid">33743756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13011-021-00360-3</pub-id><pub-id pub-id-type="pmcid">PMC7980746</pub-id></mixed-citation></ref><ref id="dar70011-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="dar70011-cit-0016"><string-name name-style="western"><given-names>J.</given-names><surname>Neale</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Nettleton</surname></string-name>, and <string-name name-style="western"><given-names>L.</given-names><surname>Pickering</surname></string-name>, &#8220;<article-title>Gender Sameness and Difference in Recovery From Heroin Dependence: A Qualitative Exploration</article-title>,&#8221; <source>International Journal on Drug Policy</source><volume>25</volume>, no. <issue>1</issue> (<year>2014</year>): <fpage>3</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="pmid">24041800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2013.08.002</pub-id></mixed-citation></ref><ref id="dar70011-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="dar70011-cit-0017"><string-name name-style="western"><given-names>S.</given-names><surname>Luthar</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Cushing</surname></string-name>, and <string-name name-style="western"><given-names>B.</given-names><surname>Rounsaville</surname></string-name>, &#8220;<article-title>Gender Differences Among Opioid Abusers: Pathways to Disorder and Profiles of Psychopathology</article-title>,&#8221; <source>Drug and Alcohol Dependence</source><volume>43</volume> (<year>1997</year>): <fpage>179</fpage>&#8211;<lpage>189</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0376-8716(96)01310-5</pub-id><pub-id pub-id-type="pmid">9023074</pub-id></mixed-citation></ref><ref id="dar70011-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="dar70011-cit-0018"><string-name name-style="western"><given-names>S. F.</given-names><surname>Greenfield</surname></string-name>, <string-name name-style="western"><given-names>A. J.</given-names><surname>Brooks</surname></string-name>, <string-name name-style="western"><given-names>S. M.</given-names><surname>Gordon</surname></string-name>, et&#160;al., &#8220;<article-title>Substance Abuse Treatment Entry, Retention, and Outcome in Women: A Review of the Literature</article-title>,&#8221; <source>Drug and Alcohol Dependence</source><volume>86</volume>, no. <issue>1</issue> (<year>2007</year>): <fpage>1</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="pmid">16759822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2006.05.012</pub-id><pub-id pub-id-type="pmcid">PMC3532875</pub-id></mixed-citation></ref><ref id="dar70011-bib-0019"><label>19</label><mixed-citation publication-type="book" id="dar70011-cit-0019"><string-name name-style="western"><given-names>S.</given-names><surname>Covington</surname></string-name>, &#8220;<part-title>Helping Women Recover: Creating Gender&#8208;Responsive Treatment</part-title>,&#8221; in <source>The Handbook of Addiction Treatment for Women: Theory and Practice</source>, ed. <person-group person-group-type="editor"><string-name name-style="western"><given-names>S.</given-names><surname>Straussner</surname></string-name></person-group> and <person-group person-group-type="editor"><string-name name-style="western"><given-names>S.</given-names><surname>Brown</surname></string-name></person-group> (<publisher-name>Jossey&#8208;Bass</publisher-name>, <year>2002</year>), <fpage>1</fpage>&#8211;<lpage>17</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="dar70011-cit-0020"><string-name name-style="western"><given-names>L.</given-names><surname>Medina&#8208;Perucha</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Scott</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Chapman</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Barnett</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Dack</surname></string-name>, and <string-name name-style="western"><given-names>H.</given-names><surname>Family</surname></string-name>, &#8220;<article-title>A Qualitative Study on Intersectional Stigma and Sexual Health Among Women on Opioid Substitution Treatment in England: Implications for Research, Policy and Practice</article-title>,&#8221; <source>Social Science &amp; Medicine</source><volume>222</volume> (<year>2019</year>): <fpage>315</fpage>&#8211;<lpage>322</lpage>.<pub-id pub-id-type="pmid">30682572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.socscimed.2019.01.022</pub-id></mixed-citation></ref><ref id="dar70011-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="dar70011-cit-0021"><string-name name-style="western"><given-names>E. L.</given-names><surname>Davis</surname></string-name>, <string-name name-style="western"><given-names>P. J.</given-names><surname>Kelly</surname></string-name>, <string-name name-style="western"><given-names>F. P.</given-names><surname>Deane</surname></string-name>, et&#160;al., &#8220;<article-title>The Relationship Between Patient&#8208;Centered Care and Outcomes in Specialist Drug and Alcohol Treatment: A Systematic Literature Review</article-title>,&#8221; <source>Substance Abuse</source><volume>41</volume>, no. <issue>2</issue> (<year>2020</year>): <fpage>216</fpage>&#8211;<lpage>231</lpage>.<pub-id pub-id-type="pmid">31638870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08897077.2019.1671940</pub-id></mixed-citation></ref><ref id="dar70011-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="dar70011-cit-0022"><string-name name-style="western"><given-names>C.</given-names><surname>Kingsley</surname></string-name> and <string-name name-style="western"><given-names>S.</given-names><surname>Patel</surname></string-name>, &#8220;<article-title>Patient&#8208;Reported Outcome Measures and Patient&#8208;Reported Experience Measures</article-title>,&#8221; <source>BJA Education</source><volume>17</volume>, no. <issue>4</issue> (<year>2017</year>): <fpage>137</fpage>&#8211;<lpage>144</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0023"><label>23</label><mixed-citation publication-type="book" id="dar70011-cit-0023"><collab collab-type="authors">Australian Commission on Safety and Quality in Health Care</collab>
, <source>Review of Patient Experience and Satisfaction Surveys Conducted Within Public and Private Hospitals in Australia</source> (<publisher-name>Australian Commission on Safety and Quality in Health Care</publisher-name>, <year>2012</year>).</mixed-citation></ref><ref id="dar70011-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="dar70011-cit-0024"><string-name name-style="western"><given-names>J.</given-names><surname>Trujols</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Iraurgi</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Oviedo&#8208;Joekes</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Gu&#224;rdia&#8208;Olmos</surname></string-name>, &#8220;<article-title>A Critical Analysis of User Satisfaction Surveys in Addiction Services: Opioid Maintenance Treatment as a Representative Case Study</article-title>,&#8221; <source>Patient Preference and Adherence</source><volume>21</volume>, no. <issue>8</issue> (<year>2014</year>): <fpage>107</fpage>&#8211;<lpage>117</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/PPA.S52060</pub-id><pub-id pub-id-type="pmcid">PMC3905099</pub-id><pub-id pub-id-type="pmid">24482571</pub-id></mixed-citation></ref><ref id="dar70011-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="dar70011-cit-0025"><string-name name-style="western"><given-names>C. J.</given-names><surname>Haynes</surname></string-name>, <string-name name-style="western"><given-names>A. K.</given-names><surname>Beck</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Wells</surname></string-name>, et&#160;al., &#8220;<article-title>Women and Opioid Use Disorder Treatment: A Scoping Review of Experiences, Use of Patient&#8208;Reported Experience Measures, and Integration of Person&#8208;Centred Care Principles</article-title>,&#8221; <source>International Journal on Drug Policy</source><volume>130</volume> (<year>2024</year>): <elocation-id>104520</elocation-id>.<pub-id pub-id-type="pmid">39003893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2024.104520</pub-id></mixed-citation></ref><ref id="dar70011-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="dar70011-cit-0026"><string-name name-style="western"><given-names>J.</given-names><surname>Trujols</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Iraurgi</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Batlle</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Dur&#225;n&#8208;Sindreu</surname></string-name>, and <string-name name-style="western"><given-names>J. P.</given-names><surname>de Los Cobos</surname></string-name>, &#8220;<article-title>Towards a Genuinely User&#8208;Centred Evaluation of Harm Reduction and Drug Treatment Programmes: A Further Proposal</article-title>,&#8221; <source>International Journal on Drug Policy</source><volume>26</volume>, no. <issue>12</issue> (<year>2015</year>): <fpage>1285</fpage>&#8211;<lpage>1287</lpage>.<pub-id pub-id-type="pmid">26372296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2015.08.012</pub-id></mixed-citation></ref><ref id="dar70011-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="dar70011-cit-0027"><string-name name-style="western"><given-names>K.</given-names><surname>Hinsley</surname></string-name>, <string-name name-style="western"><given-names>P. J.</given-names><surname>Kelly</surname></string-name>, and <string-name name-style="western"><given-names>E.</given-names><surname>Davis</surname></string-name>, &#8220;<article-title>Experiences of Patient&#8208;Centred Care in Alcohol and Other Drug Treatment Settings: A Qualitative Study to Inform Design of a Patient&#8208;Reported Experience Measure</article-title>,&#8221; <source>Drug and Alcohol Review</source><volume>38</volume>, no. <issue>6</issue> (<year>2019</year>): <fpage>664</fpage>&#8211;<lpage>673</lpage>.<pub-id pub-id-type="pmid">31281991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/dar.12965</pub-id></mixed-citation></ref><ref id="dar70011-bib-0028"><label>28</label><mixed-citation publication-type="miscellaneous" id="dar70011-cit-0028"><collab collab-type="authors">Picker Institute</collab>
, <article-title>&#8220;The Picker Principles of Person Centred Care,&#8221; 2023</article-title>, <ext-link xlink:href="https://picker.org/who-we-are/the-picker-principles-of-person-centred-care/" ext-link-type="uri">https://picker.org/who&#8208;we&#8208;are/the&#8208;picker&#8208;principles&#8208;of&#8208;person&#8208;centred&#8208;care/</ext-link>.</mixed-citation></ref><ref id="dar70011-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="dar70011-cit-0029"><string-name name-style="western"><given-names>P. J.</given-names><surname>Kelly</surname></string-name>, <string-name name-style="western"><given-names>E. L.</given-names><surname>Hatton</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Hinsley</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Davis</surname></string-name>, and <string-name name-style="western"><given-names>B.</given-names><surname>Larance</surname></string-name>, &#8220;<article-title>Preliminary Psychometric Evaluation of the Patient Reported Experience Measure for Addiction Treatment (PREMAT)</article-title>,&#8221; <source>Addictive Behaviors</source><volume>123</volume> (<year>2021</year>): <elocation-id>107048</elocation-id>.<pub-id pub-id-type="pmid">34348223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addbeh.2021.107048</pub-id></mixed-citation></ref><ref id="dar70011-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="dar70011-cit-0030"><string-name name-style="western"><given-names>G.</given-names><surname>De Leon</surname></string-name>, &#8220;<article-title>Therapeutic Communities for Addictions: A Theoretical Framework</article-title>,&#8221; <source>International Journal of the Addictions</source><volume>30</volume>, no. <issue>12</issue> (<year>1995</year>): <fpage>1603</fpage>&#8211;<lpage>1645</lpage>.<pub-id pub-id-type="pmid">8557410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/10826089509104418</pub-id></mixed-citation></ref><ref id="dar70011-bib-0031"><label>31</label><mixed-citation publication-type="book" id="dar70011-cit-0031"><string-name name-style="western"><given-names>G.</given-names><surname>De Leon</surname></string-name>, <source>The Therapeutic Community: Theory, Model, and Method</source> (<publisher-name>Springer Publishing Company</publisher-name>, <year>2000</year>).</mixed-citation></ref><ref id="dar70011-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="dar70011-cit-0032"><string-name name-style="western"><given-names>M.</given-names><surname>Anderson</surname></string-name>, <article-title>&#8220;Recovery, Relationships, and Identity: A Mixed Methods Process Evaluation of the Formation of a Therapeutic Community&#8221; (PhD thesis, University of Glasgow, 2022)</article-title>.</mixed-citation></ref><ref id="dar70011-bib-0033"><label>33</label><mixed-citation publication-type="book" id="dar70011-cit-0033"><collab collab-type="authors">Victorian Department of Health</collab>
, <source>National Mental Health Consumer Experiences of Care Project: Final Report</source> (<publisher-name>Department of Health</publisher-name>, <year>2013</year>).</mixed-citation></ref><ref id="dar70011-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="dar70011-cit-0034"><string-name name-style="western"><given-names>P. J.</given-names><surname>Kelly</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Kyngdon</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Ingram</surname></string-name>, <string-name name-style="western"><given-names>F. P.</given-names><surname>Deane</surname></string-name>, <string-name name-style="western"><given-names>A. L.</given-names><surname>Baker</surname></string-name>, and <string-name name-style="western"><given-names>B. A.</given-names><surname>Osborne</surname></string-name>, &#8220;<article-title>The Client Satisfaction Questionnaire&#8208;8: Psychometric Properties in a Cross&#8208;Sectional Survey of People Attending Residential Substance Abuse Treatment</article-title>,&#8221; <source>Drug and Alcohol Review</source><volume>37</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>79</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">28480521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/dar.12522</pub-id></mixed-citation></ref><ref id="dar70011-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="dar70011-cit-0035"><string-name name-style="western"><given-names>C.</given-names><surname>Migchels</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>van den Brink</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Zerrouk</surname></string-name>, et&#160;al., &#8220;<article-title>Psychometric Evaluation of the Dutch Version of the Patient&#8208;Reported Experience Measure for Addiction Treatment (PREMAT&#8208;NL)</article-title>,&#8221; <source>Drug and Alcohol Review</source><volume>43</volume>, no. <issue>7</issue> (<year>2024</year>): <fpage>2021</fpage>&#8211;<lpage>2034</lpage>.<pub-id pub-id-type="pmid">39256987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/dar.13939</pub-id></mixed-citation></ref><ref id="dar70011-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="dar70011-cit-0036"><string-name name-style="western"><given-names>C. C.</given-names><surname>Attkisson</surname></string-name> and <string-name name-style="western"><given-names>R.</given-names><surname>Zwick</surname></string-name>, &#8220;<article-title>The Client Satisfaction Questionnaire: Psychometric Properties and Correlations With Service Utilization and Psychotherapy Outcome</article-title>,&#8221; <source>Evaluation and Program Planning</source><volume>5</volume>, no. <issue>3</issue> (<year>1982</year>): <fpage>233</fpage>&#8211;<lpage>237</lpage>.<pub-id pub-id-type="pmid">10259963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0149-7189(82)90074-x</pub-id></mixed-citation></ref><ref id="dar70011-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="dar70011-cit-0037"><string-name name-style="western"><given-names>D. L.</given-names><surname>Larsen</surname></string-name>, <string-name name-style="western"><given-names>C. C.</given-names><surname>Attkisson</surname></string-name>, <string-name name-style="western"><given-names>W. A.</given-names><surname>Hargreaves</surname></string-name>, and <string-name name-style="western"><given-names>T. D.</given-names><surname>Nguyen</surname></string-name>,&#160;&#8220;<article-title>Assessment of Client/Patient Satisfaction: Development of a General Scale</article-title>,&#8221; <source>Evaluation and Program Planning</source><volume>2</volume>, no. <issue>3</issue> (<year>1979</year>): <fpage>197</fpage>&#8211;<lpage>207</lpage>.<pub-id pub-id-type="pmid">10245370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0149-7189(79)90094-6</pub-id></mixed-citation></ref><ref id="dar70011-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="dar70011-cit-0038"><string-name name-style="western"><given-names>E. F.</given-names><surname>De Wilde</surname></string-name> and <string-name name-style="western"><given-names>V. M.</given-names><surname>Hendriks</surname></string-name>, &#8220;<article-title>The Client Satisfaction Questionnaire: Psychometric Properties in a Dutch Addict Population</article-title>,&#8221; <source>European Addiction Research</source><volume>11</volume>, no. <issue>4</issue> (<year>2005</year>): <fpage>157</fpage>&#8211;<lpage>162</lpage>.<pub-id pub-id-type="pmid">16110221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000086396</pub-id></mixed-citation></ref><ref id="dar70011-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="dar70011-cit-0039"><string-name name-style="western"><given-names>H.</given-names><surname>Miles</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Johnson</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Amponsah&#8208;Afuwape</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Finch</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Leese</surname></string-name>, and <string-name name-style="western"><given-names>G.</given-names><surname>Thornicroft</surname></string-name>, &#8220;<article-title>Characteristics of Subgroups of Individuals With Psychotic Illness and a Comorbid Substance Use Disorder</article-title>,&#8221; <source>Psychiatric Services</source><volume>54</volume>, no. <issue>4</issue> (<year>2003</year>): <fpage>554</fpage>&#8211;<lpage>561</lpage>.<pub-id pub-id-type="pmid">12663845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ps.54.4.554</pub-id></mixed-citation></ref><ref id="dar70011-bib-0040"><label>40</label><mixed-citation publication-type="book" id="dar70011-cit-0040"><string-name name-style="western"><given-names>J.</given-names><surname>Peng</surname></string-name>, <string-name name-style="western"><given-names>C.&#8208;Y. J.</given-names><surname>Peng</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Harwell</surname></string-name>, <string-name name-style="western"><given-names>S.&#8208;M.</given-names><surname>Liou</surname></string-name>, and <string-name name-style="western"><given-names>L. H.</given-names><surname>Ehman</surname></string-name>, &#8220;<part-title>Advances in Missing Data Methods and Implications for Educational Research</part-title>,&#8221; in <source>Real Data Analysis</source>, ed. <person-group person-group-type="editor"><string-name name-style="western"><given-names>S.</given-names><surname>Sawilowsky</surname></string-name></person-group> (<publisher-name>Information Age Publishing Inc</publisher-name>, <year>2006</year>), <fpage>31</fpage>&#8211;<lpage>78</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="dar70011-cit-0041"><string-name name-style="western"><given-names>A.</given-names><surname>Jadhav</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Pramod</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Ramanathan</surname></string-name>, &#8220;<article-title>Comparison of Performance of Data Imputation Methods for Numeric Dataset</article-title>,&#8221; <source>Applied Artificial Intelligence</source><volume>33</volume>, no. <issue>10</issue> (<year>2019</year>): <fpage>913</fpage>&#8211;<lpage>933</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="dar70011-cit-0042"><string-name name-style="western"><given-names>J. W.</given-names><surname>Johnson</surname></string-name> and <string-name name-style="western"><given-names>J. M.</given-names><surname>LeBreton</surname></string-name>, &#8220;<article-title>History and Use of Relative Importance Indices in Organizational Research</article-title>,&#8221; <source>Organizational Research Methods</source><volume>7</volume>, no. <issue>3</issue> (<year>2004</year>): <fpage>238</fpage>&#8211;<lpage>257</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="dar70011-cit-0043"><string-name name-style="western"><given-names>J. W.</given-names><surname>Johnson</surname></string-name>, &#8220;<article-title>A Heuristic Method for Estimating the Relative Weight of Predictor Variables in Multiple Regression</article-title>,&#8221; <source>Multivariate Behavioral Research</source><volume>35</volume>, no. <issue>1</issue> (<year>2000</year>): <fpage>1</fpage>&#8211;<lpage>19</lpage>.<pub-id pub-id-type="pmid">26777229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1207/S15327906MBR3501_1</pub-id></mixed-citation></ref><ref id="dar70011-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="dar70011-cit-0044"><string-name name-style="western"><given-names>S.</given-names><surname>Tonidandel</surname></string-name> and <string-name name-style="western"><given-names>J. M.</given-names><surname>LeBreton</surname></string-name>, &#8220;<article-title>RWA Web: A Free, Comprehensive, Web&#8208;Based, and User&#8208;Friendly Tool for Relative Weight Analyses</article-title>,&#8221; <source>Journal of Business and Psychology</source><volume>30</volume>, no. <issue>2</issue> (<year>2015</year>): <fpage>207</fpage>&#8211;<lpage>216</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="dar70011-cit-0045"><string-name name-style="western"><given-names>D. A.</given-names><surname>Major</surname></string-name>, <string-name name-style="western"><given-names>V. J.</given-names><surname>Morganson</surname></string-name>, and <string-name name-style="western"><given-names>H. M.</given-names><surname>Bolen</surname></string-name>, &#8220;<article-title>Predictors of Occupational and Organizational Commitment in Information Technology: Exploring Gender Differences and Similarities</article-title>,&#8221; <source>Journal of Business and Psychology</source><volume>28</volume> (<year>2013</year>): <fpage>301</fpage>&#8211;<lpage>314</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="dar70011-cit-0046"><string-name name-style="western"><given-names>Z.</given-names><surname>Zhiwei</surname></string-name>, <string-name name-style="western"><given-names>D. R.</given-names><surname>Gerstein</surname></string-name>, and <string-name name-style="western"><given-names>P. D.</given-names><surname>Friedmann</surname></string-name>, &#8220;<article-title>Patient Satisfaction and Sustained Outcomes of Drug Abuse Treatment</article-title>,&#8221; <source>Journal of Health Psychology</source><volume>13</volume>, no. <issue>3</issue> (<year>2008</year>): <fpage>388</fpage>&#8211;<lpage>400</lpage>.<pub-id pub-id-type="pmid">18420772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1359105307088142</pub-id><pub-id pub-id-type="pmcid">PMC2796692</pub-id></mixed-citation></ref><ref id="dar70011-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="dar70011-cit-0047"><string-name name-style="western"><given-names>C. D.</given-names><surname>Barbosa</surname></string-name>, <string-name name-style="western"><given-names>M.&#8208;M.</given-names><surname>Balp</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Kulich</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Germain</surname></string-name>, and <string-name name-style="western"><given-names>D.</given-names><surname>Rofail</surname></string-name>, &#8220;<article-title>A Literature Review to Explore the Link Between Treatment Satisfaction and Adherence, Compliance, and Persistence</article-title>,&#8221; <source>Patient Preference and Adherence</source><volume>6</volume> (<year>2012</year>): <fpage>39</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="pmid">22272068</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/PPA.S24752</pub-id><pub-id pub-id-type="pmcid">PMC3262489</pub-id></mixed-citation></ref><ref id="dar70011-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="dar70011-cit-0048"><string-name name-style="western"><given-names>M. J.</given-names><surname>Carlson</surname></string-name> and <string-name name-style="western"><given-names>R. M.</given-names><surname>Gabriel</surname></string-name>, &#8220;<article-title>Patient Satisfaction, Use of Services, and One&#8208;Year Outcomes in Publicly Funded Substance Abuse Treatment</article-title>,&#8221; <source>Psychiatric Services</source><volume>52</volume>, no. <issue>9</issue> (<year>2001</year>): <fpage>1230</fpage>&#8211;<lpage>1236</lpage>.<pub-id pub-id-type="pmid">11533398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ps.52.9.1230</pub-id></mixed-citation></ref><ref id="dar70011-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="dar70011-cit-0049"><string-name name-style="western"><given-names>D. M.</given-names><surname>Donovan</surname></string-name>, <string-name name-style="western"><given-names>R. M.</given-names><surname>Kadden</surname></string-name>, <string-name name-style="western"><given-names>C. C.</given-names><surname>DiClemente</surname></string-name>, and <string-name name-style="western"><given-names>K. M.</given-names><surname>Carroll</surname></string-name>, &#8220;<article-title>Client Satisfaction With Three Therapies in the Treatment of Alcohol Dependence: Results From Project MATCH</article-title>,&#8221; <source>American Journal on Addictions</source><volume>11</volume>, no. <issue>4</issue> (<year>2002</year>): <fpage>291</fpage>&#8211;<lpage>307</lpage>.<pub-id pub-id-type="pmid">12584872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10550490290088090</pub-id></mixed-citation></ref><ref id="dar70011-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="dar70011-cit-0050"><string-name name-style="western"><given-names>Z. S.</given-names><surname>Morris</surname></string-name> and <string-name name-style="western"><given-names>N.</given-names><surname>McKeganey</surname></string-name>, &#8220;<article-title>Client Perceptions of Drug Treatment Services in Scotland</article-title>,&#8221; <source>Drugs: Education, Prevention and Policy</source><volume>14</volume>, no. <issue>1</issue> (<year>2007</year>): <fpage>49</fpage>&#8211;<lpage>60</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0051"><label>51</label><mixed-citation publication-type="book" id="dar70011-cit-0051"><string-name name-style="western"><given-names>E. S.</given-names><surname>Carr</surname></string-name>, <source>Scripting Addiction: The Politics of Therapeutic Talk and American Sobriety</source> (<publisher-name>Princeton University Press</publisher-name>, <year>2010</year>).</mixed-citation></ref><ref id="dar70011-bib-0052"><label>52</label><mixed-citation publication-type="book" id="dar70011-cit-0052"><string-name name-style="western"><given-names>D.</given-names><surname>Hardina</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Jane Middleton</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Montana</surname></string-name>, and <string-name name-style="western"><given-names>R. A.</given-names><surname>Simpson</surname></string-name>, <source>An Empowering Approach to Managing Social Service Organizations</source> (<publisher-name>Springer Publishing Company</publisher-name>, <year>2006</year>).</mixed-citation></ref><ref id="dar70011-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="dar70011-cit-0053"><string-name name-style="western"><given-names>T.</given-names><surname>D'Aunno</surname></string-name>, &#8220;<article-title>The Role of Organization and Management in Substance Abuse Treatment: Review and Roadmap</article-title>,&#8221; <source>Journal of Substance Abuse Treatment</source><volume>31</volume>, no. <issue>3</issue> (<year>2006</year>): <fpage>221</fpage>&#8211;<lpage>233</lpage>.<pub-id pub-id-type="pmid">16996385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsat.2006.06.016</pub-id></mixed-citation></ref><ref id="dar70011-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="dar70011-cit-0054"><string-name name-style="western"><given-names>S.</given-names><surname>Park</surname></string-name>, <string-name name-style="western"><given-names>C. M.</given-names><surname>Grogan</surname></string-name>, <string-name name-style="western"><given-names>J. E.</given-names><surname>Mosley</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Humphreys</surname></string-name>, <string-name name-style="western"><given-names>H. A.</given-names><surname>Pollack</surname></string-name>, and <string-name name-style="western"><given-names>P. D.</given-names><surname>Friedmann</surname></string-name>, &#8220;<article-title>Correlates of Patient&#8208;Centered Care Practices at US Substance Use Disorder Clinics</article-title>,&#8221; <source>Psychiatric Services</source><volume>71</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>35</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">31500544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ps.201900121</pub-id><pub-id pub-id-type="pmcid">PMC6939146</pub-id></mixed-citation></ref><ref id="dar70011-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="dar70011-cit-0055"><string-name name-style="western"><given-names>N.</given-names><surname>Uthurralt</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Miao Cao</surname></string-name>, <string-name name-style="western"><given-names>S. E.</given-names><surname>Reid</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Nithyanandam</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Burns</surname></string-name>, and <string-name name-style="western"><given-names>C. A.</given-names><surname>Day</surname></string-name>, &#8220;<article-title>Characteristics of Clients Entering Women&#8208;Only Substance Use Treatment Services in New South Wales</article-title>,&#8221; <source>Womens Health (London)</source><volume>19</volume> (<year>2023</year>): <elocation-id>17455057231200133</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/17455057231200133</pub-id><pub-id pub-id-type="pmcid">PMC10625314</pub-id><pub-id pub-id-type="pmid">37921428</pub-id></mixed-citation></ref><ref id="dar70011-bib-0056"><label>56</label><mixed-citation publication-type="book" id="dar70011-cit-0056"><collab collab-type="authors">NSW Health</collab>
, <source>Clinical Care Standards: Alcohol and Other Drug Treatment</source> (<publisher-name>NSW Health</publisher-name>, <year>2020</year>).</mixed-citation></ref><ref id="dar70011-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="dar70011-cit-0057"><string-name name-style="western"><given-names>D. M.</given-names><surname>Johnson</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Worell</surname></string-name>, and <string-name name-style="western"><given-names>R. K.</given-names><surname>Chandler</surname></string-name>, &#8220;<article-title>Assessing Psychological Health and Empowerment in Women: The Personal Progress Scale Revised</article-title>,&#8221; <source>Women &amp; Health</source><volume>41</volume>, no. <issue>1</issue> (<year>2005</year>): <fpage>109</fpage>&#8211;<lpage>129</lpage>.<pub-id pub-id-type="pmid">16048871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1300/J013v41n01_07</pub-id></mixed-citation></ref><ref id="dar70011-bib-0058"><label>58</label><mixed-citation publication-type="book" id="dar70011-cit-0058"><string-name name-style="western"><given-names>J.</given-names><surname>Worell</surname></string-name> and <string-name name-style="western"><given-names>P.</given-names><surname>Remer</surname></string-name>, <source>Feminist Perspectives in Therapy: Empowering Diverse Women</source> (<publisher-name>John Wiley &amp; Sons</publisher-name>, <year>2002</year>).</mixed-citation></ref><ref id="dar70011-bib-0059"><label>59</label><mixed-citation publication-type="book" id="dar70011-cit-0059"><string-name name-style="western"><given-names>A. H.</given-names><surname>Eagly</surname></string-name> and <string-name name-style="western"><given-names>W.</given-names><surname>Wood</surname></string-name>, &#8220;<part-title>Social Role Theory</part-title>,&#8221; in <source>Handbook of Theories of Social Psychology</source>, vol. <volume>2</volume> (<publisher-name>Springer</publisher-name>, <year>2012</year>), <fpage>458</fpage>&#8211;<lpage>476</lpage>.</mixed-citation></ref><ref id="dar70011-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="dar70011-cit-0060"><string-name name-style="western"><given-names>A.</given-names><surname>Bazen</surname></string-name>, <string-name name-style="western"><given-names>F. K.</given-names><surname>Barg</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Takeshita</surname></string-name>, &#8220;<article-title>Research Techniques Made Simple: An Introduction to Qualitative Research</article-title>,&#8221; <source>Journal of Investigative Dermatology</source><volume>141</volume>, no. <issue>2</issue> (<year>2021</year>): <fpage>241</fpage>&#8211;<lpage>247.e1</lpage>.<pub-id pub-id-type="pmid">33504436</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jid.2020.11.029</pub-id></mixed-citation></ref><ref id="dar70011-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="dar70011-cit-0061"><string-name name-style="western"><given-names>K.</given-names><surname>Jamieson Gilmore</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Corazza</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Coletta</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Allin</surname></string-name>, &#8220;<article-title>The Uses of Patient Reported Experience Measures in Health Systems: A Systematic Narrative Review</article-title>,&#8221; <source>Health Policy</source><volume>128</volume> (<year>2023</year>): <fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">35934546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.healthpol.2022.07.008</pub-id></mixed-citation></ref><ref id="dar70011-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="dar70011-cit-0062"><string-name name-style="western"><given-names>A.</given-names><surname>Madden</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Lea</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Bath</surname></string-name>, and <string-name name-style="western"><given-names>A. R.</given-names><surname>Winstock</surname></string-name>, &#8220;<article-title>Satisfaction Guaranteed? What Clients on Methadone and Buprenorphine Think About Their Treatment</article-title>,&#8221; <source>Drug and Alcohol Review</source><volume>27</volume>, no. <issue>6</issue> (<year>2008</year>): <fpage>671</fpage>&#8211;<lpage>678</lpage>.<pub-id pub-id-type="pmid">19378450</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09595230801935706</pub-id></mixed-citation></ref></ref-list><app-group><app id="dar70011-app-0001" content-type="Appendix"><label>Appendix A</label><p>STROBE Statement&#8212;Checklist of items that should be included in reports of cross&#8208;sectional studies.<table-wrap position="anchor" id="jats-table-wrap-1" orientation="portrait"><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Item no.</th><th align="center" valign="bottom" rowspan="1" colspan="1">Recommendation</th><th align="center" valign="bottom" rowspan="1" colspan="1">Page #</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="top" colspan="1">Title and abstract</td><td rowspan="2" align="center" valign="top" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">(a) Indicate the study's design with a commonly used term in the title or the abstract</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(b) Provide in the abstract an informative and balanced summary of what was done and what was found</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Introduction</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Background/rationale</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">Explain the scientific background and rationale for the investigation being reported</td><td align="center" valign="top" rowspan="1" colspan="1">4&#8211;5</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Objectives</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">State specific objectives, including any prespecified hypotheses</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Methods</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Study design</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">Present key elements of study design early in the paper</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Setting</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow&#8208;up, and data collection</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Participants</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">(a) Give the eligibility criteria, and the sources and methods of selection of participants</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Variables</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable</td><td align="center" valign="top" rowspan="1" colspan="1">6&#8211;7</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Data sources/measurement</td><td align="center" valign="top" rowspan="1" colspan="1">8<sup>a</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group</td><td align="center" valign="top" rowspan="1" colspan="1">6&#8211;7</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Bias</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">Describe any efforts to address potential sources of bias</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Study size</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">Explain how the study size was arrived at</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Quantitative variables</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why</td><td align="center" valign="top" rowspan="1" colspan="1">8&#8211;9</td></tr><tr><td rowspan="5" align="left" style="padding-left:10%" valign="top" colspan="1">Statistical methods</td><td rowspan="5" align="center" valign="top" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">(a) Describe all statistical methods, including those used to control for confounding</td><td align="center" valign="top" rowspan="1" colspan="1">8&#8211;9</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(b) Describe any methods used to examine subgroups and interactions</td><td align="center" valign="top" rowspan="1" colspan="1">8&#8211;9</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(c) Explain how missing data were addressed</td><td align="center" valign="top" rowspan="1" colspan="1">8&#8211;9</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(d) If applicable, describe analytical methods taking account of sampling strategy</td><td align="center" valign="top" rowspan="1" colspan="1">8&#8211;9</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(e) Describe any sensitivity analyses</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Results</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="3" align="left" style="padding-left:10%" valign="top" colspan="1">Participants</td><td rowspan="3" align="center" valign="top" colspan="1">13<sup>a</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">(a) Report numbers of individuals at each stage of study&#8212;e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow&#8208;up, and analysed</td><td align="center" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(b) Give reasons for non&#8208;participation at each stage</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(c) Consider use of a flow diagram</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="2" align="left" style="padding-left:10%" valign="top" colspan="1">Descriptive data</td><td rowspan="2" align="center" valign="top" colspan="1">14<sup>a</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">(a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders</td><td align="center" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(b) Indicate number of participants with missing data for each variable of interest</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Outcome data</td><td align="center" valign="top" rowspan="1" colspan="1">15<sup>a</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Report numbers of outcome events or summary measures</td><td align="center" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td rowspan="3" align="left" style="padding-left:10%" valign="top" colspan="1">Main results</td><td rowspan="3" align="center" valign="top" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">(a) Give unadjusted estimates and, if applicable, confounder&#8208;adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included</td><td align="center" valign="top" rowspan="1" colspan="1">9&#8211;10</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(b) Report category boundaries when continuous variables were categorised</td><td align="center" valign="top" rowspan="1" colspan="1">9&#8211;10</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period</td><td align="center" valign="top" rowspan="1" colspan="1">9&#8211;10</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other analyses</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">Report other analyses done&#8212;e.g., analyses of subgroups and interactions, and sensitivity analyses</td><td align="center" valign="top" rowspan="1" colspan="1">9&#8211;10</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Discussion</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Key results</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">Summarise key results with reference to study objectives</td><td align="center" valign="top" rowspan="1" colspan="1">10&#8211;12</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Limitations</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias</td><td align="center" valign="top" rowspan="1" colspan="1">12&#8211;13</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Interpretation</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence</td><td align="center" valign="top" rowspan="1" colspan="1">10&#8211;12</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Generalisability</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">Discuss the generalisability (external validity) of the study results</td><td align="center" valign="top" rowspan="1" colspan="1">12&#8211;13</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Other information</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Funding</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot id="dar70011-ntgp-0006"><fn id="dar70011-note-0010"><p>
<italic toggle="yes">Note</italic>: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at <ext-link xlink:href="http://www.plosmedicine.org/" ext-link-type="uri">http://www.plosmedicine.org/</ext-link>, Annals of Internal Medicine at <ext-link xlink:href="http://www.annals.org/" ext-link-type="uri">http://www.annals.org/</ext-link> and Epidemiology at <ext-link xlink:href="http://www.epidem.com/" ext-link-type="uri">http://www.epidem.com/</ext-link>). Information on the STROBE Initiative is available at <ext-link xlink:href="http://www.strobe-statement.org" ext-link-type="uri">www.strobe&#8208;statement.org</ext-link>.</p></fn><fn id="dar70011-note-0011"><label>
<sup>a</sup>
</label><p>Give information separately for exposed and unexposed groups.</p></fn></table-wrap-foot></table-wrap>
</p></app><app id="dar70011-app-0002" content-type="Appendix"><label>Appendix B</label><table-wrap position="anchor" id="dar70011-tbl-0005" content-type="TABLE" orientation="portrait"><label>TABLE B1</label><caption><p>PREMAT item scores by gender.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">Item</th><th rowspan="2" align="center" valign="bottom" colspan="1">Domain</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total (<italic toggle="yes">N</italic>&#8201;=&#8201;129)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Men (<italic toggle="yes">n</italic>&#8201;=&#8201;88)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Women (<italic toggle="yes">n</italic>&#8201;=&#8201;41)</th><th rowspan="2" align="center" valign="bottom" colspan="1">Difference <italic toggle="yes">U</italic>, <italic toggle="yes">p</italic>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">M</italic> (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">M</italic> (SD)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">1. I have been supported to start doing things that I want to do</td><td align="center" valign="top" rowspan="1" colspan="1">IS</td><td align="center" valign="top" rowspan="1" colspan="1">3.85 (0.99)</td><td align="center" valign="top" rowspan="1" colspan="1">3.87 (0.99)</td><td align="center" valign="top" rowspan="1" colspan="1">3.81 (1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.007, <italic toggle="yes">p</italic>&#8201;=&#8201;0.934</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2. I feel better about myself because of this program</td><td align="center" valign="top" rowspan="1" colspan="1">SDE</td><td align="center" valign="top" rowspan="1" colspan="1">4.13 (0.85)</td><td align="center" valign="top" rowspan="1" colspan="1">4.14 (0.81)</td><td align="center" valign="top" rowspan="1" colspan="1">4.12 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.454, <italic toggle="yes">p</italic>&#8201;=&#8201;0.501</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3. I am more aware of myself because of this program</td><td align="center" valign="top" rowspan="1" colspan="1">SDE</td><td align="center" valign="top" rowspan="1" colspan="1">4.29 (0.77)</td><td align="center" valign="top" rowspan="1" colspan="1">4.31 (0.69)</td><td align="center" valign="top" rowspan="1" colspan="1">4.23 (0.95)</td><td align="center" valign="top" rowspan="1" colspan="1">0.496, <italic toggle="yes">p</italic>&#8201;=&#8201;0.481</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4. I have enough privacy here</td><td align="center" valign="top" rowspan="1" colspan="1">TE</td><td align="center" valign="top" rowspan="1" colspan="1">3.61 (1.13)</td><td align="center" valign="top" rowspan="1" colspan="1">3.67 (1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">3.47 (1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">0.126, <italic toggle="yes">p</italic>&#8201;=&#8201;0.723</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5. I am given enough space by other people in this program</td><td align="center" valign="top" rowspan="1" colspan="1">TE</td><td align="center" valign="top" rowspan="1" colspan="1">3.65 (1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">3.68 (1.06)</td><td align="center" valign="top" rowspan="1" colspan="1">3.58 (1.20)</td><td align="center" valign="top" rowspan="1" colspan="1">0.430, <italic toggle="yes">p</italic>&#8201;=&#8201;0.512</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6. I better understand why I have used drugs and/or alcohol because of this program</td><td align="center" valign="top" rowspan="1" colspan="1">SDE</td><td align="center" valign="top" rowspan="1" colspan="1">4.02 (1.03)</td><td align="center" valign="top" rowspan="1" colspan="1">4.09 (0.92)</td><td align="center" valign="top" rowspan="1" colspan="1">3.88 (1.24)</td><td align="center" valign="top" rowspan="1" colspan="1">0.454, <italic toggle="yes">p</italic>&#8201;=&#8201;0.501</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7. I have enough one&#8208;to&#8208;one sessions</td><td align="center" valign="top" rowspan="1" colspan="1">IS</td><td align="center" valign="top" rowspan="1" colspan="1">3.44 (1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">3.41 (1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">3.55 (1.19)</td><td align="center" valign="top" rowspan="1" colspan="1">1.264, <italic toggle="yes">p</italic>&#8201;=&#8201;0.261</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8. I am supported to look after my health, financial and legal problems</td><td align="center" valign="top" rowspan="1" colspan="1">IS</td><td align="center" valign="top" rowspan="1" colspan="1">3.75 (1.13)</td><td align="center" valign="top" rowspan="1" colspan="1">3.77 (1.07)</td><td align="center" valign="top" rowspan="1" colspan="1">3.72 (1.26)</td><td align="center" valign="top" rowspan="1" colspan="1">1.163, <italic toggle="yes">p</italic>&#8201;=&#8201;0.281</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9. I can get help for any difficulties I have</td><td align="center" valign="top" rowspan="1" colspan="1">IS</td><td align="center" valign="top" rowspan="1" colspan="1">3.90 (1.02)</td><td align="center" valign="top" rowspan="1" colspan="1">3.95 (0.92)</td><td align="center" valign="top" rowspan="1" colspan="1">3.86 (1.15)</td><td align="center" valign="top" rowspan="1" colspan="1">1.163, <italic toggle="yes">p</italic>&#8201;=&#8201;0.281</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10. I know what the rules are and what will happen if I don't follow the rules</td><td align="center" valign="top" rowspan="1" colspan="1">PR</td><td align="center" valign="top" rowspan="1" colspan="1">4.30 (0.82)</td><td align="center" valign="top" rowspan="1" colspan="1">4.27 (0.92)</td><td align="center" valign="top" rowspan="1" colspan="1">4.37 (0.82)</td><td align="center" valign="top" rowspan="1" colspan="1">2.187, <italic toggle="yes">p</italic>&#8201;=&#8201;0.139</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11. I think the rules make sense</td><td align="center" valign="top" rowspan="1" colspan="1">PR</td><td align="center" valign="top" rowspan="1" colspan="1">3.90 (0.97)</td><td align="center" valign="top" rowspan="1" colspan="1">3.86 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">3.98 (1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">2.647, <italic toggle="yes">p</italic>&#8201;=&#8201;0.104</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12. My day is structured here</td><td align="center" valign="top" rowspan="1" colspan="1">PS</td><td align="center" valign="top" rowspan="1" colspan="1">4.22 (1.09)</td><td align="center" valign="top" rowspan="1" colspan="1">4.19 (1.09)</td><td align="center" valign="top" rowspan="1" colspan="1">4.29 (1.11)</td><td align="center" valign="top" rowspan="1" colspan="1">Not comp.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13. I am provided with a schedule so that I know what to do with my time</td><td align="center" valign="top" rowspan="1" colspan="1">PS</td><td align="center" valign="top" rowspan="1" colspan="1">4.14 (1.04)</td><td align="center" valign="top" rowspan="1" colspan="1">4.12 (1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">4.26 (1.08)</td><td align="center" valign="top" rowspan="1" colspan="1">1.520, <italic toggle="yes">p</italic>&#8201;=&#8201;0.218</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14. I am provided with opportunities to exercise</td><td align="center" valign="top" rowspan="1" colspan="1">PS</td><td align="center" valign="top" rowspan="1" colspan="1">3.91 (1.04)</td><td align="center" valign="top" rowspan="1" colspan="1">4.02 (0.86)</td><td align="center" valign="top" rowspan="1" colspan="1">3.69 (1.33)</td><td align="center" valign="top" rowspan="1" colspan="1">0.874, <italic toggle="yes">p</italic>&#8201;=&#8201;0.350</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15. I am provided with fresh fruit and vegetables</td><td align="center" valign="top" rowspan="1" colspan="1">TE</td><td align="center" valign="top" rowspan="1" colspan="1">3.89 (1.02)</td><td align="center" valign="top" rowspan="1" colspan="1">3.89 (1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">3.88 (1.09)</td><td align="center" valign="top" rowspan="1" colspan="1">1.163. <italic toggle="yes">p</italic>&#8201;=&#8201;0.281</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16. I think this place is clean and hygienic</td><td align="center" valign="top" rowspan="1" colspan="1">TE</td><td align="center" valign="top" rowspan="1" colspan="1">3.84 (1.05)</td><td align="center" valign="top" rowspan="1" colspan="1">3.85 (0.99)</td><td align="center" valign="top" rowspan="1" colspan="1">3.83 (1.17)</td><td align="center" valign="top" rowspan="1" colspan="1">1.879, <italic toggle="yes">p</italic>&#8201;=&#8201;0.170</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17. I feel supported and understood by other people in this program</td><td align="center" valign="top" rowspan="1" colspan="1">SDE</td><td align="center" valign="top" rowspan="1" colspan="1">3.91 (0.93)</td><td align="center" valign="top" rowspan="1" colspan="1">3.98 (0.85)</td><td align="center" valign="top" rowspan="1" colspan="1">3.74 (1.08)</td><td align="center" valign="top" rowspan="1" colspan="1">0.049, <italic toggle="yes">p</italic>&#8201;=&#8201;0.825</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18. Staff treat me like a person and not an addict</td><td align="center" valign="top" rowspan="1" colspan="1">IS</td><td align="center" valign="top" rowspan="1" colspan="1">4.19 (0.91)</td><td align="center" valign="top" rowspan="1" colspan="1">4.15 (0.89)</td><td align="center" valign="top" rowspan="1" colspan="1">4.30 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">2.163, <italic toggle="yes">p</italic>&#8201;=&#8201;0.141</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19. I am supported to focus on my recovery</td><td align="center" valign="top" rowspan="1" colspan="1">PS</td><td align="center" valign="top" rowspan="1" colspan="1">4.20 (0.93)</td><td align="center" valign="top" rowspan="1" colspan="1">4.17 (0.93)</td><td align="center" valign="top" rowspan="1" colspan="1">4.28 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">1.470, <italic toggle="yes">p</italic>&#8201;=&#8201;0.225</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20. My family and friends have been provided with information about recovery</td><td align="center" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">3.29 (1.33)</td><td align="center" valign="top" rowspan="1" colspan="1">3.38 (1.32)</td><td align="center" valign="top" rowspan="1" colspan="1">3.15 (1.33)</td><td align="center" valign="top" rowspan="1" colspan="1">0.073, <italic toggle="yes">p</italic>&#8201;=&#8201;0.787</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21. I am more able to cope with my everyday life outside the program</td><td align="center" valign="top" rowspan="1" colspan="1">SDE</td><td align="center" valign="top" rowspan="1" colspan="1">3.86 (1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">3.86 (1.11)</td><td align="center" valign="top" rowspan="1" colspan="1">3.88 (1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">0.639, <italic toggle="yes">p</italic>&#8201;=&#8201;0.424</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22. I have been linked up with other services to support me when I leave this program</td><td align="center" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">3.33 (1.31)</td><td align="center" valign="top" rowspan="1" colspan="1">3.30 (1.31)</td><td align="center" valign="top" rowspan="1" colspan="1">3.39 (1.32)</td><td align="center" valign="top" rowspan="1" colspan="1">1.317, <italic toggle="yes">p</italic>&#8201;=&#8201;0.270</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23. I can get information from staff about where else I can go for help</td><td align="center" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">3.66 (1.30)</td><td align="center" valign="top" rowspan="1" colspan="1">3.68 (1.27)</td><td align="center" valign="top" rowspan="1" colspan="1">3.63 (1.40)</td><td align="center" valign="top" rowspan="1" colspan="1">1.496, <italic toggle="yes">p</italic>&#8201;=&#8201;0.221</td></tr></tbody></table><table-wrap-foot id="dar70011-ntgp-0007"><fn id="dar70011-note-0012"><p>Abbreviations: CC, coordination of care; IS, individualised support; PR, personal responsibility; PS, program structure; SDE, self&#8208;determination and empowerment; TE, treatment environment.</p></fn></table-wrap-foot></table-wrap><p>See Table&#160;<xref rid="dar70011-tbl-0005" ref-type="table">B1</xref>.</p></app><app id="dar70011-app-0003" content-type="Appendix"><label>Appendix C</label><fig position="anchor" fig-type="FIGURE" id="dar70011-fig-0001" orientation="portrait"><label>FIGURE C1</label><caption><p>Proposed model of the relationship between PREMAT domains and overall treatment satisfaction. Item wording and loading on domains based on Kelly et&#160;al. [<xref rid="dar70011-bib-0029" ref-type="bibr">29</xref>]. Dotted lines indicate relationships to be analysed in the current study.</p></caption><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="DAR-44-1691-g001.jpg"/></fig><p>See Figure&#160;<xref rid="dar70011-fig-0001" ref-type="fig">C1</xref>.</p></app></app-group></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>